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Abstract
Peptide Nucleic Acid (PNA), is a mimic of natural nucleic acids with exceptional binding
properties. As such, numerous applications in biochemistry, medicine and biotechnology for PNA
exist or have been proposed so far. Pseudo-complementary PNAs containing diaminopurine and
thiouracil base pairs have been prepared and are shown to bind with high specificity and efficiency
to complementary targets in double-stranded DNA by a mechanism termed ‘‘double duplex
invasion’’ in which the duplex is unwound and both DNA strands are targeted simultaneously,
each by one of the two pseudo-complementary PNAs. Chapter 2 describes a method for the
preparation of modified nucleic acids and PNA oligomerization which can be used to study
different pseudo-complementarity and base pairing and open up the possibility for the preparation
of PNA oligomers with interesting new properties. Within the realm of PNA synthesis, we have
examined different benzyl-type protections for the thiouracil nucleobase in PNA synthesis and
oligomerization. We have also demonstrated for the first time that PNA oligomer synthesis can
proceed without thiouracil protecting group on sulfur. Finally, the thermal stability of PNA
bindings and pseudo-complementary PNA were studied.
As a part of the study of pseudo-complementary nucleobases, an optimized method of assaying
DNA strand invasion by PNA was investigated. Traditional methods require time-consuming gel
assays and lack an easily quantifiable marker. Instead, our method incorporates the fluorescent
cytidine base analogue phenylpyrrolocytidine (PhpC) into a DNA strand such that upon invasion
by PNA fluorescence increases when excited. We also synthesized pseudo-complementary PNA
sequences that can undergo DNA invasion; no gels are required as all measurements are performed
in solution. Nucleic acid detection takes place by changing either the reporter’s fluorescence
intensity or the colour of its fluorescence. The use of fluorescent probes for nucleic acid detection
has attracted much attention due to its efficiency, the ease of synthesis and availability of
commercial reporters that facilitate the probe synthesis.
Chapter 3 describes the synthesis of a novel quinazolinone-based uracil PNA monomers. Their
photophysical properties were evaluated in different solvents and at varying temperatures. These
luminescent PNA monomers show solvatochromism and solvent viscosity-dependent emission
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which indicate that they have the potential to act fluorescent reporters of hybridization events once
incorporated into PNA oligomers which will be done as future work for this study.

Keywords
Peptide nucleic acid, pseudo-complementary nucleic acid, nucleobase-modified PNA, solid-phase
synthesis, thiouracil protecting groups, dihydroquinazolinone, quinazolinone, quinazolinone based
nucleobase
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Summary for Lay Audience
Peptide Nucleic Acid (PNA), is a mimic of natural nucleic acids, also known as the building blocks
of DNA, with exceptional binding properties. As such, numerous applications in biochemistry,
medicine and biotechnology for PNA exist or have been proposed so far. Pseudo-complementary
PNAs containing diaminopurine and thiouracil base pairs have been prepared and are shown to
bind with high specificity and efficiency to complementary targets in double-stranded DNA by a
mechanism termed ‘‘double duplex invasion’’ in which the duplex is unwound and both DNA
strands are targeted simultaneously, each by one of the two pseudo-complementary PNAs. The
present work describes a method for the preparation of modified nucleic acids, and PNA
oligomerization which can be used to study different pseudo-complementarity and base pairing
and open up the possibility for the preparation of PNA oligomers with interesting new properties.
Oligomerization is the process of making oligomers which are molecular complexes of chemicals
that consist of repeating units. Within the realm of PNA synthesis, we have examined different
acid-labile protections for the thiouracil nucleobase in PNA synthesis and oligomerization. We
have also demonstrated for the first time that PNA oligomer synthesis can proceed without
thiouracil protecting group on sulfur. Finally, the thermal stability of PNA bindings and pseudocomplementary PNA were studied. As a part of the study of pseudo-complementary nucleobases,
an optimized method of assaying, or making, DNA strand invasion by PNA was investigated.
Traditional methods require time consuming gel assays and lack an easily quantifiable marker.
Instead, our method incorporates the fluorescent cytidine base analogue phenylpyrrolocytidine
(PhpC) into a DNA strand such that upon invasion by PNA fluorescence increases when excited.
We also synthesized pseudo-complementary PNA sequences that can undergo DNA invasion; no
gels are required for this process, as all measurements are performed in solution.
Nucleic acid detection takes place by changing either the reporter’s fluorescence intensity or
the colour of its fluorescence. The use of fluorescent probes for nucleic acid detection has
attracted much attention due to its efficiency, the ease of synthesis and availability of
commercial reporters that facilitate the probe synthesis. Chapter 3 describes the synthesis of a
novel quinazolinone-based uracil PNA monomers. The study of photophysical properties in
different solvents and temperatures show that they can be good fluorescent reporters upon
iv

hybridization with the complementary DNA sequence by incorporation of these PNA monomers
into PNA oligomers as the future work for this study.
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Chapter 1

1. General Introduction to Pseudo-Complementary Nucleic Acids
Nucleic acids are an essential component of all known life, with DNA containing the
hereditary information for all eukaryotes and prokaryotes. DNA contains a sugar-phosphodiester
backbone composed of β-2-deoxyribose sugars combined by phosphate at the 3-to-5-hydroxyl of
sugars. Each sugar contains one of thymine, adenine, guanine, cytosine nucleobases attached to
the C-1 position of the sugar. Nucleic acid strands can undergo hybridization between
complementary base pairs cytosine and guanine, thymine and adenine to form a double-strand
duplex1. Adenine forming two hydrogen bonds with thymine and guanine forms three hydrogen
bonds with cytosine and these bonding patterns between nucleobases provides specificity of base
pairing (Figure 1.1). The duplex is not only stabilized due to hydrophilic interactions between the
charged phosphate backbone and aqueous environment, but also by the hydrophobic interactions
between the nucleobases. Hydrogen bonding between complementary nucleobases and π-stacking
from the aromatic purine and pyrimidine nucleobases will also stabilize the duplex formation,
while mismatched nucleobases destabilize the duplex.

Figure 1.1 Watson-Crick base pairing between nucleobases (A) thymine and adenine (B)
cytosine and guanine
Design of nucleic acid oligomers is approachable due to DNA synthetic methods and the
specificity resulting from base complementary and allows chemists for reaching specific
1

hybridization with DNA or RNA targets, known as molecular probes. This specificity allows the
design of nucleic acid probes for research and genetic screening, as well as potential design of
nucleic acid-based therapeutic agents, which rely on highly specific targeting of a genetic
sequence. Oligonucleotide sequences provide the required specificity through base pairing
between complementary nucleobases and targeting of a specific genetic sequence can prevent
undesired off-targeting effects.
One of the major limitations to oligodeoxynucleotides (ODNs) use in in vivo application
results from the instability of nucleic acid strands. ODN strands are susceptible to hydrolysis by
nucleases, enzymes responsible for cleaving phosphodiester bonds, preventing ODNs from
reaching the desired target. Many chemical modifications have been developed to increase the
stability of nucleic acid oligomers. Sugar-phosphodiester backbone modifications increase the
stability in vivo as it prevents recognition and degradation by nucleases. Modification such as
replacing the phosphate units with analogs like phosphothioates or phosphoborates or replacing
the ribose sugar provide resistance to nucleases. However, these modifications often introduce
chiral centers and reduce the binding affinity between the oligomer and the target DNA or RNA
strand.

1.2 Peptide nucleic acid chemistry
Replacement of the sugar-phosphate backbone with an aminoethylglycine backbone with
the nucleobases attached via a methylene carbonyl linker is one type of modification which forms
a peptide nucleic acid (PNA). The modified backbone is oligomerized through peptide bonds
between an N-terminal amine and a C-terminal carboxylic acid to form a PNA oligomer.
Advantages of peptide nucleic acids include, the unnatural backbone is resistant to degradation
from either nucleases or proteases, as the backbone is not recognized as either an oligonucleotide
or a polypeptide for cleavage. In addition, the aminoethylglycine backbone maintains natural
spacing observed with the sugar-phosphodiester backbone, allowing normal Watson-Crick base
pairing with modified DNA, RNA, and PNA strands. The PNA oligomers can undergo more stable

2

hybridization with DNA and RNA than ODNs due to the neutral aminoethylglycine backbone,
ODNs experience anionic repulsion due to the negatively charged phosphate groups present in the
backbone. (Figure 1.2) Having high sequence specificity for hybridization, with a single base
mismatch significantly destabilizing a PNA-DNA duplex, which is one of the PNA features. The
aminoethyl glycine is achiral, allowing for the easy synthesis of PNA monomers without difficult
purification, and the pseudo-peptide bonds allow for easy oligomerization using standard solidphase peptide synthesis (SPPS) techniques.

Figure 1.2 Chemical structure of peptide nucleic acid oligomer (PNA), deoxyribose nucleic
acid oligomer (DNA), and amino acid oligomer (peptide).

3

1.3 Potential applications
1.3.1 Therapeutics
Potential therapeutic applications for PNA arise from their ability to selectively and
strongly bind either DNA or RNA and inhibit biological processes. Although their poor cellular
uptake is the main obstacle to their effective therapeutic use, enthusiasm for the use of PNA has
been regained because of the discovery of a class of peptides with translocating properties and
capable of carrying compounds across the plasma membrane.2 Additionally, it was surprisingly
found that PNA is able to enter the prokaryote E. coli.3

1.3.2 Applications in biotechnology
In particular, DNA targeting by triplex-forming oligonucleotides and helix-invading
triplex-forming PNAs is still basically limited to homopurine targets because of the involvement
of third-strand Hoogsteen recognition.4 However, general sequence recognition by the invasion of
the DNA double helix exploiting just the Watson–Crick base pairing principle might be
accomplished by helix invasion using duplex-forming PNAs. Unfortunately, mixed purinepyrimidine sequence PNAs do not provide sufficient free energy upon hybridization for this mode
of binding. However, the required free energy could be gained if both DNA strands were targeted
simultaneously (Figure 1.3). Naturally, the two PNAs (or oligonucleotides) would be sequence
complementary and if composed of the natural nucleobases A, C, G, and T would ‘‘quench’’ each
other by forming a stable duplex. Thus, PNA oligomers do not undergo duplex invasion of a
double-stranded DNA duplex, which is a major limitation of PNAs for many biological
applications involving gene targeting. Hybridizing a complementary PNA oligomer to both strands
of the complementary DNA duplex is one method to overcome this entropic restriction. However,
the double duplex invasion using PNA oligomers is hindered by the strong hybridization of PNAs,
which results in highly stable PNA-PNA hybridization, which is more favorable than PNA-DNA
hybridization. As a result, the use of complementary PNA oligomers in a double duplex invasion
instead of results in the formation of a stable PNA-PNA duplex leaving the target DNA duplex
4

intact.5 The design of unnatural nucleoside analogues is one of the main goals of medicinal
chemistry, with different applications such as antiviral chemotherapeutics or in nucleic acid
detection.
The unnatural nucleobase 2,6-diaminopurine (D) has found the interest for its strong and
selective base pairing to uracil/thymine6. The placement of adenine with D in PNA is one of the
simplest ways to increase the binding to a target nucleic acid. (Figure 1.4.)

Figure 1.3. Modes of hybridization between PNA oligomer and nucleic acid duplex.
Pseudo-complementary nucleobases, first reported by Gamper et al. for DNA.7 In 1999,
Nielsen et al.6 developed a method for destabilizing the PNA-PNA duplex, which utilized modified
pseudo-complementary nucleobases to synthesize selectively binding oligomers, or pseudocomplementary PNAs (pcPNAs). The first synthesis of pcPNA oligomers using a Boc-based SPPS
approach and demonstrating their ability to undergo a double duplex invasion of a target DNA
duplex have been reported by Nielsen et al.6 (Figure 1.4.)

5

Figure 1.4. Base pairing of natural and pseudo-complementary nucleobases A) adenine and
thymine, B) diaminopurine and thymine, C) adenine and thiouracil, D) diaminopurine and
thiouracil

Basically, two SPPS methods have been used for chemical oligomerization in peptide
synthesis, which primarily differs in the protecting group strategy. All amino acids contain both a
carboxylic acid and an amine, which undergo a condensation reaction to form an amide linkage
during oligomerization, which must be protected and require different deprotection conditions for
control of sequence-specific oligomerization. Moreover, many amino acids contain reactive side
chains, which require separate functional group protection. Similarly, PNAs contain both a
carboxylic acid and a primary amine, which require separate protection and deprotection strategies,
with most nucleobases requiring further protection during oligomerization.
Peptide synthesis was performed using gradient acidolysis protection strategies where Nterminal Boc deprotection occurred under relatively weaker acidic conditions, while C-terminal
deprotection required stronger acidic conditions. Advances in chemical synthesis lead to the
development of an orthogonal protection strategy with N-terminal Fmoc group for which
deprotection occurred under weakly basic conditions and C-terminal deprotection occurring under
6

weakly acidic conditions. This strategy results in higher-yielding oligomerization, and as a result,
can be used to synthesize longer peptide sequences. Both strategies have been modified for
standard PNA oligomerization, with standard monomers commercially available for synthesis.
The original synthesis of PNA oligomers was reported by Egholm, Nielsen et al. in 19926
which utilized the Boc-based technique developed by Merrifield for solid-phase peptide synthesis.8
This procedure uses a tert-butyloxycarbonyl protecting group on the terminal amine, while the Cterminal of the oligomer is attached to a solid support, typically a cross-linked polystyrene resin,
by a 4-methyl benzhydrylamine linker. The nucleobases were protected using acid-labile
protecting groups; so, oligomer deprotection can occur concurrently with resin cleavage under
strongly acidic conditions.
A severe limitation of Boc-based peptide synthesis is the final deprotection and resin
cleavage that requires strongly acidic treatment with hydrofluoric acid, which can damage the
oligomer and the harsh reagents can be dangerous to work with. Orthogonal protection strategy
which uses fluorenylmethyloxycarbonyl (Fmoc) protection on the terminal amine, which requires
weakly basic conditions for deprotection can be used9. Normal deprotection conditions, which is
a mixture of 20% v/v piperidine solution in dimethylformamide to remove the Fmoc protection,
can be used for oligomerization on the N-terminal. By using Fmoc protection, more acid-labile
protecting groups can be used for the C-terminal and nucleobase protection. An acid-labile linker
is used to attach the polystyrene resin to the C-terminal of the oligomer. Nucleobase protection
uses a more acid-labile Boc or benzhydryloxycarbonyl (Bhoc) group to protect the exocyclic
amines on cytosine, adenine, and guanine allowing resin cleavage and the final deprotection of the
oligomer to be performed using a solution of 95% v/v trifluoroacetic acid and 5% triethylsilane as
a cation scavenger. This orthogonal protection strategy uses milder deprotection conditions and
typically results in higher-yielding oligomerization compared to the Boc-based protection strategy.
Due to these advantages, the Fmoc protection strategy has become the standard for the chemical
synthesis of peptides and PNA oligomers.

7

Scheme 1.1. SPPS cycle for oligomerization with Fmoc/Bhoc based protecting group

1.4 Goals of this research
Until recently, the synthesis of pcPNA oligomers was carried out using Boc-based
oligomerization strategy which has become unfavourable due to harsh deprotection conditions
which result in lower-yielding reactions thus limiting oligomer length. Therefore, the primary aim
of this work is to develop a highly acid-labile protecting group for thiouracil/thiothymine so that
the PNA monomer is compatible with Fmoc-based PNA oligomerization (Scheme 1.1). The
Fmoc-based thiouracil and diaminopurine PNA monomer were prepared and the binding study
was done. Also, the need for keeping thiouracil protecting group during oligomerization, as well
as the acid resistance of 2-methoxybenzyl protection was studied. And at the end, in our study
toward the pseudo-complementary base pairs, we aimed to develop a more efficient method for
detecting and quantifying duplex invasion by using fluorescent analysis.
8

1.5 Introduction to fluorescent nucleobases
Since the 1980s, much effort has been devoted to exploit using fluorescence techniques in the
detection of nucleic acids. Aromatic-based amino acids (phenylalanine, tyrosine and/or
tryptophan) are characterized by their intrinsic fluorescence that may be used in fluorescent
studies; but natural nucleic acids are known to be nonfluorescent10,11. Due to the promising results
shown for the detection of nucleic acid using fluorescent probes, intensive research has been
devoted to design and synthesize nucleobases possessing fluorescent properties. There is a great
demand for such nucleobases, especially ones that are fluorescent while maintaining the hydrogen
bonding ability to the complementary nucleobases.
Fluorescent nucleobases are classified by Tor12 into five major families as 1) isomorphic base
analogues, 2) pteridines, 3) expanded nucleobases, 4) chromophoric base analogues and 5)
conjugated base analogues.

1) Isomorphic base analogues, heterocyclic compounds characterized by its similarity to the
natural nucleobases in overall dimension and their ability to Watson-Crick base pairing. The most
common example of this class is 2-aminopurine (2-AP). 2-AP is an analog of guanine and adenine
and therefore it can pair with thymine and uracil obeying Watson-Crick base pairing.13 2-AP is
distinguished by its high fluorescence quantum yield (F = 0.68 in aqueous solution) and high
sensitivity to the local environment. Upon incorporation of 2-AP into a nucleic acid, the
fluorescence intensity of 2-AP was drastically reduced ~100 times due to stacking interactions
with nearest neighbor nucleobases. This reduction in 2-AP quantum yield is highly dependent on
base sequence.13 Owing to 2-AP sensitivity to the microenvironment, it has been widely used in
several studies of nucleic acid structure and dynamics within DNA and RNA.14
2) Pteridines, purine analogues, are bicyclic planar compounds formed from two condensed sixmembered rings and are distinguished by their ability to form hydrogen bonds with complementary
bases in addition to their intensive emission quantum yield (F = 0.77-0.88 for adenosine
analogues and 0.39-0.48 for the guanosine)15 (Figure 1.5). Pteridines have been employed in
numerous applications as hybridization probes which are used in measuring the cleavage activity
of the retrovirally coded protein, human immunodeficiency virus-1 (HIV-1) integrase.16
9

Figure 1.5 Examples of pteridine derivatives
3) Expanded nucleobases are natural nucleobases that have been extended with fused aromatic
rings. Etheno-A,16 the simplest example of fluorescent extended nucleobases with quantum yield
= 0.54 (in dioxane-H2O 1:1), it was prepared by reaction of chloroacetaldehyde with adenosine.
Despite the fluorescence property of Etheno-A, it cannot engage in hydrogen bonding. Much work
has been done to extend the nucleobases structures while retaining their ability to hydrogen bond
with complementary nucleobases (Figure 1.6).17

Figure 1.6 Examples of expanded nucleobases
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4) Chromophoric base analogues, are produced when the natural nucleobases are replaced by
hydrocarbons and heterocyclic residues that are characterized by their emission such as pyrene,
phenanthrene, terphenyl, terthiophene, benzoterthiophene and coumarin (Figure 1.7).18 Using
multiple dyes as replacement of DNA bases in adjacent position in DNA sequences can be used in
the detection of a genetic sequence. For example, pyrene is a well-characterized excimer-forming
fluorophore. When it is used alone it emits blue light while using two units of pyrene leads to
emission of green light ascribed to the formation of an excimer complex through energy transfer
from one pyrene unit to the other.

Figure 1.7 Examples of hydrocarbons and heterocycle DNA base replacement
5) Conjugated base analogues, are the fluorescent aromatic residues that are conjugated to the
nucleobases via a linker. This class is characterized by introducing fluorescent property from the
aromatic residue and maintaining the hydrogen bond ability with their complementary nucleobase.
Numerous C5 or C6 modified pyrimidine nucleosides and C2 or C8 modified purine nucleosides
have been synthesized in last 40 years employing the transition-metal assisted cross-coupling
reactions 19,20 Some of them show potent biological activity and/or are utilized as mechanistic or
labelling probes (Figure 1.8). For example, the bicyclic furanopyrimidine-2-one nucleoside
analogues bearing an aryl side chain display remarkable antiviral potency against the VaricellaZoster virus. The 5-thienyl-deoxyuridines or 5-furyl-deoxyuridines were used as molecular
beacons for oligonucleotide labeling. 21
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Figure 1.8 Examples of some conjugated base analogues

To date, different modified pyrimidines, extensively explored and utilized, contain a
modification as a conjugated aromatic residue at 5-position. Herein we will discuss the preparation
of emissive and highly responsive pyrimidines containing quinazolinone-based aromatic
heterocycles that possess a molecular rotor element.

1.5.1 Quinazolinone-based nucleobase scaffolds
Many of the current treatment regimes for cancer utilize compounds which inhibit DNA
synthesis. Such compounds are toxic to cells generally but their toxic effect on the rapidly dividing
tumor cells can be beneficial. Alternative approaches to anti-cancer agents which act by
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mechanisms other than the inhibition of DNA synthesis have the potential to display enhanced
selectivity of action against cancer cells.
In recent years it has been discovered that a cell may become cancerous by virtue of the
transformation of a portion of its DNA into an oncogene i.e. a gene which, on activation, leads to
the formation of malignant tumor cells28. Heterocycle moieties, such as quinazolinones, are present
in natural products21 and synthetic pharmaceutical compounds24. These compounds have been
extensively studied for their biological and therapeutic activities.
Sequential recognition of metal ions and anions by a new fluorescent quinazolinone based probe
has been achieved by previous studies23,30. These probes exhibit highly selective and sensitive
fluorescence “OFF-ON” recognition properties to metal ions and display high selectivity to anions
through fluorescence relay enhancement22. It is well established that quinazolinone derivatives can
show fluorescent properties, also the effect of adding electron donating and electron-withdrawing
groups on the fluorescent intensity of some heterocyclic fluorophores have been studied31.

1.5.2 Goal of this research
Based on the aforementioned properties of either quinazolinone as a fluorogenic molecule
or in peptide nucleic acid (PNA) as artificial nucleic acid analog with remarkable binding ability,
we are interested in: first, the study of electron-withdrawing and electron-donating group effect on
fluorescent properties of quinazolinone-based uracil scaffolds and second by investigating the
photophysical properties of different functionalized quinazolinone-based uracil scaffold, and
synthesis of PNA monomer possessing quinazolinone moiety. Incorporation of quinazolinonebased PNA monomer in PNA oligomer may be used as reporter probe for DNA detection in
addition to its potential stabilization of the duplex structure by increased stacking interactions.
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Chapter 2
Highly acid-labile protecting group for thiouracil
2.1 Introduction
The normal oligomerization of peptide nucleic acids (PNAs) is based on peptide synthesis
procedure.{Bibliography}31 Although uracil and thymine nucleobase monomers normally do not
require protection as they do not contain nucleophilic exocyclic amino groups, replacing the
carbonyl group of T and U with a thionyl group at the 2-position of the nucleobase creates a
nucleophilic site. Due to the greater nucleophilicity of sulfur compared to nitrogen, alkylation of
the unprotected nucleobase with methylene carbonyl linker results in S-alkylation rather than the
desired N-1-alkylation. Therefore, protection of the sU nucleobases is necessary due to the
nucleophilicity of the thiol group.

Scheme 2.1 Retro-synthesis of thiouracil PNA monomer with different acid labile benzyltype protection
In 1999, Nielsen et al.6 developed the synthesis of a protected thiouracil (sU) monomer
compatible with PNA oligomerization under the SPPS condition. They used 4-methoxybenzyl
protection on the 2-thiol position of the nucleobase, which can be removed under strongly acidic
17

conditions used for global deprotection. The protected thiouracil nucleobase is then attached to the
protected aminoethyl glycine backbone via a methylene carbonyl linker to yield the sU monomer
for oligomerization (Scheme 2.2). The sU monomer is then incorporated into PNA oligomers using
standard Boc-based SPPS procedures.

Scheme 2.2. PNA monomer compatible with Boc-based peptide synthesis6.
An orthogonal protection system, which removes protecting groups and cleaves the peptide
from the solid support resin under acidic condition, is being used in modern SPPS technique. Due
to the mild conditions used for global deprotection, this work aims to develop a more acid-labile
protecting strategy for the sU monomer, which can be easily removed. The methoxy group can act
as an electron donation group on the benzyl-type protection and helps stabilize the carbocation
formed from acidolysis of the protecting group. We proposed increasing the electron donation into
the benzylic position would increase the stability of the transition state (Scheme 2.3.). The
stabilization of the cationic product can be reached by using a more acid-labile protecting group,
which can be removed under milder acidolysis conditions. However, we found that 2methoxybenzyl protection is surprisingly very acid resistant and cannot be used for Fmoc-based
synthesis in PNA synthesis procedure.
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Scheme 2.3 Different studied benzyl-type protection for thiouracil

2.2 Results and discussions
2.2.1 Thiouracil protection with 4-methoxybenzyl and 2methoxybenzyl group
In order to study the effects of the addition of methoxy substituent to the ortho- and parapositions of the benzene ring on the rate of the acidolysis of the benzyl protecting group from the
thiol of the thiouracil nucleobase, the 4-methoxybenzyl (5) protected and 2-methoxybenzyl
protected (11a) thiouracil were synthesized. The 4-methoxybenzyl thiouracil (5) has been used in
the original synthesis of the thiouracil monomer for Boc-based oligomerization and it was
synthesized as a comparison for the more acid-labile thiol protecting groups. The 2,4,6trimethoxybenzyl and 2,4-dimethoxybenzyl thiouracil protection have been synthesized in Dr.
Hudson’s research group previously by Timothy Martin-Chan. In this work, a 2-methoxybenzyl
protecting group was studied as the sulfur protection. The 2-methoxybenzaldehyde was reduced
using sodium borohydride (Scheme 2.4), to yield 2-methoxybenzyl alcohol as the product. Then
benzyl alcohol was halogenated using thionyl chloride to replace the hydroxyl group with a good
leaving group for addition onto the thiouracil nucleobase. The 2-methoxybenzyl chloride was
extracted in ether to yield the compound as a clear colourless oil. The 2-methoxybenzyl group was
added to thiouracil using potassium hydroxide as the base, which yielded the 2-(2methoxybenzyl)thiouracil as a white solid. The protected thiouracil was then alkylated using ethyl
bromoacetate in a solution of sodium ethoxide, which yielded a mixture containing both N-119

alkylation and O-4-alkylation of the nucleobase, which can be separated by column
chromatography. The 34% yield was reached for N-1-alkylated product, while the O-4-alkylated
product resulted in 11% yield. Although the reaction progressed in low yield, the unreacted S-(2methoxybenzyl)thiouracil was easily separated by column chromatography and reacted with ethyl
bromoacetate and sodium ethoxide in a second alkylation reaction to increase the yield of the
desired N-1-alkylated product (Scheme 2.4.).

Scheme 2.4. Synthesis of 2-methoxybenzyl protected thiouracil nucleobase
The purified product (11a) characterized by 2D NMR analysis to determine the exact
structure of the synthesized compound. Three possible alkylations of the protected sU nucleobase
could be formed. N-1 position or N-3 position common with alkylation of uracil and O-alkylation
of the carbonyl at the 4-position also possible. Analysis of the 1H NMR, 13C NMR, COSY, HSQC,
and HMBC have been done and HMBC spectra looks at the interactions between the methylene
protons with the carbon atoms of the thiouracil ring. It is expected that for the desired N-1
alkylation, the interaction would be observed with the C-2 and C-6 atoms while N-3 alkylation
20

would result in interaction between the methylene carbonyl protons and the C-2 and C-4 atoms.
Just the first outcome is observed in the HMBC spectra. Also, interactions between the methylene
carbonyl protons and the C-4 and C-5 atoms indicating O-alkylation of thiouracil nucleobase
(Figure 2.1.).

Figure 2.1. Possible structures of alkylation products of 10. Selected NOE correlations
(double-headed arrows) and HMBC H-C correlations (single-headed arrows) of compounds
11a and 11b.
The ESI-MS data of compound 11a with a molecular mass of ([M+H]+ 214.04121 found
214.04042) was collected . Based on the mass of the synthesized compound and its 2D NMR data
suggest that there are two different final products. The N-1-alkylated compound (11a) subjected
to the acidolysis analysis and the data was compared to other methoxybenzyl-type protected
thiouracil nucleobases (Table 1.1.). The acid cleavage of the thiol-protecting group was confirmed
under standard deprotection conditions used for global deprotection of PNA oligomers synthesized
using Fmoc-based oligomerization.
The N-1-alkylated S-(4-methoxybenzyl)thiouracil was mixed with a solution of 2%
trifluoroacetic acid in 0.5 mL of deuterated chloroform and 1 drop of triethylsilane in order to
monitor the deprotection of benzyl-type protection. The 1H NMR spectra of the obtained product
show the removal of the thiol protecting group under these conditions (Figure S1). The absence
of the aromatic benzyl protons and the benzylic protons in the NMR spectra proved the removal
of the 4-methoxybenzyl group. This test confirmed the acid lability of the sulfur protecting group
under standard deprotection conditions suggesting that once used into PNA oligomerization, using
Fmoc-based chemistry, the thiouracil nucleobases could be easily deprotected during the global
deprotection and resin cleavage of the PNA oligomer.
21

The N-1-alkylated S-(2-methoxybenzyl)thiouracil was mixed with a solution of 2%
trifluoroacetic acid in 0.5 mL of deuterated chloroform and 1 drop of triethylsilane and the
progression of acidolysis was monitored by 1H NMR. Surprisingly, 2-methoxybenzyl protected
thiouracil showed strong acid resistance in 2% and 10% trifluoroacetic acid, which cannot be
explained by the proposed deprotection mechanism (Scheme 2.5). So, a more concentrated
solution was prepared by using 95% of trifluoroacetic acid and it took 50 minutes to fully deprotect
the thiol position and remove the 2-methoxybenzyl group (Table 2.1).

Scheme 2.5. Proposed mechanism of 2-methoxybenzyl thiol protecting group acidolysis.

Protecting group

Nucleobase

Rate constant (k)

SU
4-methoxybenzyl
0.0111
a
S
4-methoxybenzyl
T
0.0070
a
S
2-methyl-4-methoxybenzyl
U
0.0527
SU
2,4-dimethoxybenzyla
S
2-methoxybenzyl
U
a
2,4,6-trimethoxybenzyl
a
Studied by Timothy Martin-Chan from Hudson Group
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Half-life (𝒕𝟏/𝟐 ) (min)
62
99
13
<1
-

Table 2.1 The rate and half-life of acidolysis for different benzyl-type protections in the
solution of 2% of trifluoroacetic acid condition.
In order to elucidate the strong

acidolysis resistance mechanism of S-(2

methoxybenzyl)thiouracil, the minimum energy structure for the S-(2-methoxybenzyl)thiouracil
has been studied (Figure 2.2).

(a)

(b)

Figure 2.2. (a) Proposed stabilization of the protonated form of compound 14a by an
intramolecular hydrogen bond with the 2-methoxybenzyl group. (b) Minimum energy
structure for the protonated model compound S-(2-methoxybenzyl)-N1-methylthiouracil.
Arrowheads show the S→H distance (1.853 Å); O→N3 distance (2.854 Å).
According to the Hammet equation32, there is a linear free-energy relationship relating reaction
rates and equilibrium constants for many reactions involving benzoic acid derivatives with metaand para-substituents to each other with just two parameters: a substituent constant and a reaction
constant. However, in the case of ortho substituents, the Hammet equation is not valid because of
the steric hindrance effects. The hydrogen bonds with donor-acceptor distances in the range of 2.2
to 2.5 Å considered as strong, 2.5 to 3.2 Å considered as moderate, and 3.2-4.0 Å is considered
as a weak bond32. In this molecule, as it is shown in (Figure 2.2) the distance between oxygen
atom in methoxy group and a hydrogen atom attached to N-3 position is 1.853 Å, which is suitable
for forming a strong hydrogen bond. Therefore, forming a hydrogen bond with the proton on the
N-3 position stabilizes the intermediate and prevents the normal deprotection mechanism to occur.
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As it is shown in (Figure 2.2), the hydrogen bond formed will stabilize the lone pairs on
oxygen in the methoxy group attached to the benzyl ring and it reduces its ability to act as an
electron-donating group; so the deprotection needs stronger acid concentration to go to completion.

2.2.2 Thiouracil PNA monomer
The Fmoc-based aminoethylglycine backbone was synthesized as a hydrochloride salt in
our research group previously by following literature procedures33,34. The hydrochloride salt
backbone was extracted in chloroform to yield the compound as a clear and colourless oil (13).
The alkylacetate of the protected nucleobase was hydrolyzed using a solution of aqueous
lithium hydroxide, to obtain the carboxylic acid functional group for attachment to the
aminoethylglycine backbone. The protected nucleobase was then reacted with a solution of
hexafluorophosphate benzotriazole tetramethyl uronium (HBTU), which acts as the coupling
agent, and diisopropylethylamine (DIPEA) which acts as the base. The activated nucleobase is
then reacted with the protected aminoethylglycine (14) backbone to form the PNA monomer. The
methyl ester protecting the C-terminus of the PNA monomer is then hydrolyzed using aqueous
lithium hydroxide solution to form the C- terminus carboxylic acid. Because of the kinetics of the
reactivity of the C-terminus protecting group compared to the N-terminus protecting group under
aqueous alkali conditions favours hydrolysis of the methyl ester instead of removal of the Fmoc
group, which can give the selective deprotection of the PNA backbone (Scheme 2.6).
Basic conditions to remove the Fmoc protecting group uses a solution of 20% piperidine
(pKa=11). Amine bases are effective in the removal of the Fmoc group since removing the Fmoc
group results in the formation of highly reactive dibenzofulvene as a byproduct of the reaction,
which is trapped by the amine base. Amine bases such as piperidine effectively trap the
dibenzofulvene intermediate which drives the deprotection reaction to completion.35,36
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Scheme 2.6. Synthesis of thiouracil PNA monomer
After C-terminus methyl ester hydrolysis, which gives desired PNA monomer, the
oligomerization can be done. The monomers were characterized using 1H NMR and
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C NMR

spectroscopy as well as high-resolution mass spectrometry (HRMS). 1H NMR spectra show the
presence of rotameric structures which caused by amide bond formed between the methylene
carbonyl linker and the aminoethylglycine backbone and resulting from the carbamate from Fmoc
protection on the N-terminus.
After the successful PNA monomer and oligomer synthesis with protected nucleobases, it
has been not stated using thiouracil monomers with protecting groups during the oligomerization
is necessary. As stated above, the protecting group on the thio position is necessary in order to get
the desired N-1-alkylation. So, the thiouracil PNA monomer was synthesized without methoxy
25

benzyl type protections. PNA monomer (16) added to a solution of 95% trifluoroacetic acid and
5% triethylsilane and it was stirred for 30 min. The solvent was then evaporated under a nitrogen
stream and the resulting residue was washed twice with toluene to remove the protecting group
from the nucleobase and give protection free-PNA monomer (17) (Scheme 2.7)

Scheme 2.7. Synthesis of protection-free thiouracil PNA monomer

2.2.3 Tetrakis-Boc protected 2,6-diaminopurine PNA monomer
The synthesis of tetrakis-Boc protected 2,6-diaminopurine was done by penta-Boc
protection of the commercially available 2,6-diaminopurine to form 19, which proceeded in high
yield (Scheme 2.7) 2,6-diaminopurine is insoluble in THF, and as it reacts the product becomes
fully soluble. After that, the mono-deprotection using NaHCO3 in MeOH gives 20. The tetrakisBoc protected nucleobase was subjected to an alkylation using benzyl bromoacetate, and the bulky
protecting group directed the alkylation to N-9 position. The hydrogenation of the benzyl ester 21
gave the final tetra-Boc protected nucleobase acid 22 in high yield, before the coupling step.37
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Scheme 2.8. The synthesis of tetrakis-(Boc)-2,6-diaminopurine-9-yl acetic acid.

2.2.3.1 Coupling of Boc-protected acid 2,6-diaminopurine
monomer to PNA backbone
The coupling of the Boc-protected acids to the previously synthesized Fmoc/Bn PNA
backbone in our lab was done using standard EDC/HOBt coupling reagents in DCM and proceeded
in typical coupling yield. (Scheme 2.8) The hydrogenation of the benzyl protecting group with
Pd/C and hydrogen gas in methanol affords the PNA monomer ready for oligomerization in high
yield (96%).

Scheme 2.9. The coupling of the Boc-protected acids to an Fmoc/Bn PNA backbone to form
PNA monomer
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2.2.4 Oligomerization of PNA Fmoc-based PNA monomers
The peptide synthesis was carried out using the thiothymine, thiouracil (with and without
protecting group) and 2,6-diaminopurine PNA monomers, in order to show that the Fmoc/Boc
protection strategy was effective for the synthesis of PNA and also the protection for sulfur is not
necessary during the oligomerization and 4-methoxybenzyl type protection is labile enough for
thiouracil.
The mass spectroscopy results and HPLC traces of crude and pure thiouracil PNA oligomers (with
and without protection) showed comparable purity coupling yields to previous PNA syntheses in
our laboratory. Melting temperature determination of the PNAs with their PNA and DNA
complements was performed (Table 2.2.) to measure the effect of pseudo-complementarity and
nucleobase mismatches on PNA and DNA duplex stability.
A DNA oligomer with an analogue of cytidine, phenylpyrrolocytidine (PhpC) insert has the
advantage of being fluorescent and an experiment was done to see if this property could be
exploited to see the effect of pseudo-complementary nucleobases on fluorescent intensity upon
hybridization since PhpC introduced a mild stabilizing effect of ~2.5 °C as consistent with reported
literature.38 Also, SU bases were found to be slightly greater at destabilizing the duplex than the ST
bases.

2.2.5 Fluorescent studies
Naturally, a method is required to visualize DNA strand invasion and the effect of pseudocomplementarity, and in our study toward the pseudo-complementary base pairs, we aimed to
develop a more efficient method for detecting and quantifying duplex invasion. The current
method of gel separation, while effective, is time-consuming. Gel separation is based upon charge
to mass ratio; if DNA and PNA of identical sequences are run on the gel, a DNA duplex travels
furthest, PNA duplex the least distance, and if hybridization has occurred, a DNA-PNA duplex
will show on the gel at an intermediate distance39. One major issue with this method is due to the
uncharged PNA; it often does not migrate on the gel and thus, it cannot be visualized.
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Our proposed method aims to move away from gel separation and instead adopt a novel
fluorophore design incorporated into the strands. In our proof of concept study, we aim to
incorporate a fluorescent base, 6-phenylpyrrolocytidine (PhpC) (Figure 2.3.), near the end of a
synthesized DNA strand. When in duplex form, this modified cytidine will have low fluorescence
as it is quenched by local base stacking and its pairing to the complementary strand38. Upon duplex
invasion by complementary PNA strands at the sequence adjacent to the PhpC site (i.e. they are a
few bases shorter than the DNA strand length), the PhpC site will be freed from its base-pairing
interactions and become a short overhang region. Upon excitation at 364 nm, fluorescence at 446
nm38 will be used to monitor invasion of the DNA duplex by the pseudo-complementary PNA.

Figure 2.3. 6-phenylpyrrolocytidine (PhpC)
This method is inherently attractive due to the simplicity of fluorescence measurement, and
the subsequent ability to not only qualitatively monitor strand invasion, but also qualitatively
measure its extent and the dynamics (rate) of the process.
We previously synthesized pseudo-complementary PNA strands, and for this reason, we decided
to incorporate the PhpC into the DNA strand; in future studies, this base could be alternatively
incorporated into the PNA strand. Primarily, we will synthesize the complementary DNA strands
to the PNAs including both unmodified DNA strands and the PhpC substituted strands.
Fluorescent studies will then be performed using the PNAs and either the control DNA or the PhpC
sequences (in solution), which will show a turning-on of fluorescence when a PNA strand invades
our PhpC modified DNA sequence (Figure 2.4).
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dsDNA

pcPNA:DNA

DNA: pcPNA

pcPNA

more stable/more emissive

less stable/less emissive

Figure 2.4. DNA strand invasion by pseudo-complementary PNA (circle represents PhpC).
The more stable PNA-DNA duplexes liberate the quenched PhpC base resulting in a
turning-on of fluorescence.
Overall, this design aims to be more efficient, precise and versatile than the previous
methods; the ability to synthesize fluorescent molecules in exact locations greatly increases the
specificity of the method. Future applications could eventually include simpler detection of
specific genetic markers by in vitro hybridization studies involving on-off fluorescent switches or
even in vivo gene silencing using PNAs that visually report their binding to the target. Our goal is
to lay the foundation for this potentially significant advancement in invasion detection and to
design a simple protocol for its use in vitro.

2.2.6 Thermal stability (Tm) analysis
PNA oligomers were purified by high-pressure liquid chromatography (HPLC). They were
homogeneous by HPLC analysis and exhibited one major peak at the expected mass as analyzed
by high-resolution mass spectrometry (HRMS) (Table S1.). Thermal stability analyses (Tm) were
measured in 10 mM sodium hydrogen phosphate/ 100 mM NaCl / 0.1 mM EDTA, pH=7.0 at a
heating rate of 0.7 °C/min (15-90 °C, for PNA-PNA duplexes), (15-85 °C, for PNA-DNA
duplexes) and (10-70 °C for DNA-DNA duplexes). The thermal stability analyses have been done
in order to study binding interaction between target vs. control and target vs. modified PNA and
DNA strands using Varian 300 Bio UV-Vis Spectrometer at the wavelength of 260 nm and the
resulting data are shown below (Table 2.2.).
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vs. DNA*
Sequence (N

C)

Tm (°C)

vs. PNA†
ΔTm

Tm(°C)

ΔTm

H-Lys-GTAGATCACT-Lys-NH2

54.5

67.5

H-Lys-GsTAGAsTCACsT-Lys-NH2

62.0 (66.5)**

+7.5 (+12.0) **

64.5

-3.0

H-Lys-GsUAGAsUCACsU-Lys-NH2

57.0 (64.0)**

+2.5(+9.5) **

68.5

+1.0

H-Lys-GsUDGDsUCDCT-Lys-NH2

66.0 (70.5) **

+11.5(+16.0) **

79.5 (40.5)§ (49.0) ‡

+12 (-27.0) § (-18.5) ‡

H-Lys-AGTGATCTAC-Lys-NH2

54.5

H-Lys-AGsUGAsUCsUAC-Lys-NH2

45.0

-9.5

69.0

+1.5

H-Lys-DGsUGDsUCsUDC-Lys-NH2

59.0

+4.5

74.5

+7.0

5’ AGTGATCTACCT 3’

46.0 (48.5)**

67.5

54.5

PNA oligomers are listed from the pseudo 5’ terminus to the pseudo 3’-end. Lys = D-lysine, ST = 2-thiothymine
S

U= 2-thiouracil D= 2,6-diaminopurine PNA residues;

The complementary DNA oligonucleotides 5’ AGTGATCTACCT 3’ and 5’ AGGTAGATCACT 3’ were used.

*

Measured vs. 5’ AGTGATCTAC(PhpC)T 3’. PhpC = 6-Phenylpyrrolocytidine

**

†

The complementary PNA oligomers H-Lys-AGTGATCTAC-Lys-NH2 or H-Lys-GTAGATCACT-Lys-NH2 were

used.
Temperature-dependent UV spectra of PNA-PNA duplexes at 2 uM strand concentration each in 100 mM sodium
phosphate buffer, pH = 7.0.
‡

Measured vs. H-Lys-AGsUGAsUCsUAC-Lys-NH2.

§

Measured vs. H-Lys-DGsUGDsUCsUDC-Lys-NH2.

Table 2.2. Thermal stabilities (Tm) of complexes
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2.2.7 Fluorescence analysis
The same samples prepared for the melting studies were used (2.0 μM
of each strand in buffer). A suitable excitation wavelength was measured first by observing
emission at 446 nm; 369 nm resulted in the highest counts per second. Subsequently, the four
samples measured for fluorescence were excited at this wavelength and emission values recorded
from 400-580 nm. Excitation maximum of the PhpC base in the target DNA (PhpC) oligo was
determined to be 369 nm by measuring emission at 446 nm (Figure S4) which is consistent with
previously reported values.40 This excitation wavelength was used for subsequent measurement of
the emission spectra from 400 nm to 580 nm for each of four different target DNA (PhpC)
containing samples (Figure 2.5).

25000

Counts [s-1]
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0
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Emission Wavelength (nm)
Target DNA (PhpC)

cDNA - Target DNA (PhpC)

(sT) cPNA - Target DNA (PhpC)

(sU) cPNA - Target DNA (PhpC)

Figure 2.5. Emission spectra of four target DNA (PhpC) samples upon excitation at 369
nm.
A maximal emission was ~23000 counts per second for the single-stranded target DNA
(PhpC); this was deemed as the “ON” state. The “OFF” state was determined to be ~10000 counts
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per second as measured for the cDNA - Target DNA (PhpC) duplex. Integration of the emission
curves was consistent with an approximate doubling in overall fluorescence between the “ON”
and “OFF” states. Intermediate values were observed for the two alternate “ON” duplex states with
the cPNA (SU) - Target DNA (PhpC) measuring ~18000 counts per second and ~15000 for the
cPNA (ST) - Target DNA (PhpC).
Upon hybridization of dsPNA with dsDNA fluorescence intensity will increase over time showing
the spontaneous dsDNA invasion with ds pcPNA taking place completely after ~45 min at 39.5
°C (Figure 2.6a). Using pcPNA and complementary DNA strands with PhpC insert, duplex
denaturation was also examined by variable temperature fluorescence studies (Figure 2.6b). The
results are comparable to those obtained by temperature-dependent UV-vis spectroscopy and
showing fluorescence “OFF” and “ON” states upon hybridization to complementary oligomer and
dissociation.
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Figure 2.6. Time-dependent (a-top) and Temperature-dependent (b-bottom) fluorescence
spectra for pseudo-complementary H-Lys-GsUDGDsUCDCT-Lys-NH2 and H-LysDGsUGDsUCsUDC-Lys-NH2 PNA strands annealed with complementary 5’
AGTGATCTACCT 3’ and 5’ AGTGATCTAC(PhpC)T 3’ DNA strands. Strand
concentration is 2 mM in a buffer containing NaCl (100 mM), EDTA (0.1 mM), and Na2PO4
(10 mM, pH 7.0). Fluorescence excitation at λ=369 nm and integrated emission spectra from
400 nm to 580 nm were measured in triplicate.

2.3 Conclusion
In summary, this study has shown that the 4-methoxybenzyl protection that has been used
for Boc-based peptide synthesis containing thiouracil residues is also suitable for Fmoc-based
oligomerization. Given that the 4-methoxybenzyl protecting group is removed rapidly under the
same deprotection conditions as the N-Boc protecting group, the thiouracil protection most likely
does not persist for Boc-based oligomer synthesis. This observation prompted us to examine the
oligomerization of thiouracil PNA without nucleobase protection, which was successful. It is
noteworthy that the solubility of the unprotected thiouracil PNA monomer is suitable for
34

oligomerization chemistry; thus, it appears that only role the protecting groups serves is to allow
regioselective alkylation of N1 during monomer synthesis. A method to achieve regioselective N1
alkylation in the absence of 2-thiocarbonyl protection would be a significant benefit to monomer
preparation. Although the 4-methoxybenzyl protecting group is suitable for Fmoc-based synthesis,
milder cleavage conditions are achieved with Kittaka’s 2-methyl-4-methoxybenzyl group. In
comparison, the 2-methoxybenzyl protecting group was surprisingly robust and may find use in
combination with highly acid labile resins (such as trityl-based) for the preparation of oligomers
retaining the S-protecting group for further, post oligomerization chemistry. The origin of the
resistance to acidolysis for the 2-methoxy group appears to be intramolecular stabilization of the
protonated species and cannot be expected without this particular structural feature. Analysis of
the results from melting curves suggests several general trends. Replacement of a C base with
PhpC resulted in an increase in melting temperature; a stabilizing effect must be occurring. This
could be due to PhpC engaging in greater π-π stacking interactions compared to unmodified
cytidine. Secondly, as expected, a general increase in melting temperature was observed between
DNA-PNA heteroduplexes. Even though the PNA sequences were two base pairs shorter than their
DNA partner, the decrease in repulsion due to the neutrality of the PNA backbone resulted in
increased Tm values. Finally, it appears that with regards to DNA-PNA bonding, ST in PNA has a
slightly stronger bonding interaction with DNA than does a SU base. This was consistent across
all cases when bonding to either the target DNA or target DNA (PhpC). Interestingly, when
bonding to complementary PNA this phenomenon is reversed; PNA with SU has the higher Tm. In
the sequence context examined, the ST insert resulted in a mild destabilization (∆Tm = -1.0/insert)
relative to T, whereas SU had a slight stabilizing effect (∆Tm = +0.3/insert). This phenomenon
requires further investigation but likely is a result of the different conformation of PNA-DNA
versus PNA-PNA duplexes. The sU and D monomer incorporation into a PNA shows that and its
melting temperature against PNA and DNA shows that the synthesis of PNA sequences containing
additional pseudo-complementary bases can destabilize the PNA-PNA duplex while the DNAPNA duplex is more stable. Fluorescence measurements were highly successful and were
supportive of the original hypothesis. The target DNA (PhpC) baseline was initially compared to
the target DNA (PhpC) pared to cDNA. The change between the “ON” and “OFF” states
respectively was clearly evident as an overall change in fluorescence was approximately two-fold.
Also, as expected, the fluorescence of the DNA-PNA hybrids in the “ON” state was intermediate
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between the free Target DNA (PhpC) strand and its “OFF” partner. These results are encouraging
because it is evident that a simple change in a binding partner can be used to induce a measurable
change in fluorescence corresponding to its identity. Interestingly, using the cPNA strand with SU
resulted in slightly higher fluorescence than its ST counterpart. This may be explained by the
slightly weaker bonding interaction of the SU resulting in a more “open” duplex and thus less
quenching of the PhpC base.

2.4 Experimental Procedures

Synthesis of 2-((4-methoxybenzyl)thio)pyrimidin-4(1H)-one

4-methoxybenzyl alcohol (2)

To a solution of 4-methoxybenzaldehyde 1 (10 g, 95% purity, 73 mmol) in EtOH (40 mL)
was added NaBH4 (3.0 g, 80 mmol) portion-wise and the mixture was stirred at room temperature
for 10 min. After the addition of H2O (300 mL), the reaction mixture was acidified until pH=4
with 4 M HCl and extracted with Et2O (80 mL ×3). The combined organic layers were washed
with H2O, brine, dried over anhydrous sodium sulfate, and the solvent evaporated in vacuo after
filtration to give alcohol 2 (9.2 g, 66.6 mmol, 91%) as a clear colorless oil. 1H NMR (400 MHz,
CDCl3) δ 7.27 (d, J = 8.4 Hz, 2H), 6.86 (d, J = 8.4 Hz, 2H), 4.58 (s, 2H), 3.77 (s, 3H), 1.61 (br s,
1H). This closely corresponded to the 1H NMR spectrum previously reported in the literature.6
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2-(4-methoxybenzyl)thiouracil (5)
To a solution of 2 (9.2 g, 66.6 mmol) in CH2Cl2 (200 mL) was added SOCl2 (5.4 mL, 74.2
mmol) dropwise at 0 °C. After stirring at the same temperature for 20 min, the reaction mixture
was poured into saturated aqueous NaHCO3 (250 mL) with crushed ice. The resulting mixture was
extracted with Et2O (100 mL ×3). The combined organic layers were washed with H2O, brine,
dried over anhydrous sodium sulfate, and the solvent evaporated in vacuo after filtration. Crude
chloride 3 (9.7 g, 8.46 mL, 62 mmol) was subjected to the next reaction without further
purification. To a suspension of 2-thiouracil 4 (5 g, 39 mmol) in EtOH (50 mL) was added aqueous
KOH solution (2.8 g KOH in 20 mL H2O, 50.7 mmol) and the mixture was warmed to 45 °C to
completely dissolve 2-thiouracil. After cooling to room temperature, crude chloride 3 (62 mmol)
in EtOH (10 mL) was added to the solution and the reaction mixture was stirred at room
temperature overnight. The mixture was evaporated to dryness and the crude product was
suspended in saturated aqueous NaHCO3 (50 mL). The resulting precipitate was collected by
filtration and washed with H2O, EtOH, EtOAc, and Et2O to give 5 (8.4 g, 33.9 mmol, 87%) as a
white solid. The 1H NMR and 13C NMR spectra of the product is matched the literature spectra
reported by Nielsen et. al.31 1H NMR 1H NMR (400 MHz, Chloroform-d) δ 7.89 (d, J = 6.6 Hz,
1H), 7.36 – 7.30 (m, 2H), 6.87 (d, J = 2.1 Hz, 2H), 6.23 (d, J = 6.6 Hz, 1H), 4.42 (s, 2H), 3.81 (s,
3H).13C}1H} NMR (101 MHz, DMSO-d6) δ 176.6, 161.5, 159.0, 142.6, 130.7, 129.2, 114.4,
105.7, 55.5, 33.7.

Synthesis of N-1-(Ethyloxycarboxymethyl)-S-(4-methoxybenzyl)-2-thiouracil
(6a)
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Under the nitrogen atmosphere, sodium (620 mg, 27 mmol) was dissolved in refluxing
absolute EtOH (40 ml) and was added to a suspension of 5 (6.4 g, 26 mmol) in EtOH (30 mL) and
heated to reflux. To the reaction mixture was added ethyl bromoacetate (1.26 mL, 11.4 mmol) and
reflux was continued for 2 h. Ethyl bromoacetate (4.7 g, 3.1 mL, 27 mmol) was added and reflux
was continued for 3 h. The resulting mixture was cooled to room temperature and EtOH was
removed under reduced pressure. Water (15 mL) was added, and the mixture was extracted with
CH2Cl2 /MeOH (3:1, 60mL) twice. The organic phase was evaporated to dryness, taken up in ethyl
acetate/hexane, and again evaporated. The residue was triturated in cold ethyl acetate (10 ml),
whereby the product precipitated. It was filtered off and washed with cold ethyl acetate to afford
6a as a white solid. Yield: 2.7 g (2.7 g, 8 mmol, 30.7%). The 1H NMR and 13C NMR spectra of
the product is matched the literature spectra reported by Nielsen et. al.31

1

H NMR (600 MHz,

DMSO-d6) δ 7.64 (d, J = 7.6 Hz, 1H), 7.31 (d, J = 8.7 Hz, 2H), 6.85 (d, J = 8.7 Hz, 2H), 5.91 (d,
J = 7.5 Hz, 1H), 4.76 (s, 2H), 4.33 (s, 2H), 4.13 (q, J = 7.1 Hz, 2H), 3.70 (s, 3H), 1.15 (t, J = 7.1
Hz, 3H); 13C}1H} NMR (101 MHz, DMSO-d6) δ 167.5, 166.88, 162.8, 159.2, 146.1, 130.9, 128.4,
114.4, 109.1, 62.2, 55.5, 52.4, 40.6, 40.4, 40.2, 40.0, 39.7, 39.6, 39.4, 34.8, 14.4.

Synthesis of 2-((2-methoxybenzyl)thio)pyrimidin-4(1H)-one

2-(2-methoxybenzyl) thiouracil (10)
To a solution of 2-methoxybenzaldehyde 7 (5.0 g, 95% purity, 36.5 mmol) in EtOH (20
mL) was added NaBH4 (1.5 g, 40 mmol) portion-wise and the mixture was stirred at room
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temperature for 10 min. After the addition of H2O (150 mL), the reaction mixture was acidified
until pH=4 with 4 M HCl and extracted with Et2O (40 mL × 3). The combined organic layers were
washed with H2O, brine, dried over anhydrous sodium sulfate, and the solvent evaporated in vacuo
after filtration to give alcohol 8 (4 g, 28.9 mmol, 79%) as a clear yellow oil. Then, to a solution of
8 (4 g, 28.9 mmol) in CH2Cl2 (100 mL) was added SOCl2 (5.4 mL, 32.0 mmol) dropwise at 0 °C.
After stirring at the same temperature for 20 min, the reaction mixture was poured into saturated
aqueous NaHCO3 (150 mL) with crushed ice. The resulting mixture was extracted with Et2O (100
mL × 3). The combined organic layers were washed with H2O, brine, dried over anhydrous sodium
sulfate, and the solvent evaporated in vacuo after filtration. Crude chloride 9 (4.7 g, 4.1 mL, 30
mmol) was subjected to the next reaction without further purification. To a suspension of 2thiouracil 4 (2.4 g, 19 mmol) in EtOH (25 mL) was added aqueous KOH solution (1.4 g KOH in
10 mL H2O, 25.3 mmol) and the mixture was warmed to 45 °C to completely dissolve 2-thiouracil.
After cooling to room temperature, crude chloride 9 (30 mmol) in EtOH (5 mL) was added to the
solution and the reaction mixture was stirred at room temperature overnight. The mixture was
evaporated to dryness and the crude product was suspended in saturated aqueous NaHCO3 (50
mL). The resulting precipitate was collected by filtration and washed with H2O, EtOH, EtOAc,
and Et2O to give 10 (5.4 g, 21.9 mmol, 87%) as a white solid. 1H NMR (400 MHz, DMSO-d6) δ
7.90 (d, J = 6.5 Hz, 1H), 7.37 (dd, J = 7.4, 1.8 Hz, 1H), 7.28 (ddd, J = 8.2, 7.4, 1.8 Hz, 1H), 7.02
(dd, J = 8.3, 1.1 Hz, 1H), 6.89 (td, J = 7.4, 1.1 Hz, 1H), 6.09 (d, J = 6.5 Hz, 1H), 4.34 (s, 2H), 3.83
(s, 3H); 13C}1H} NMR (101 MHz, DMSO-d6) δ 174.6 ,157.6, 130.8, 129.5, 124.9, 120.7, 111.4,
56.0, 29.3. HRMS (ESI/Q-TOF) m/z: [M+H]+ Calcd for C12H12N2O2S 248.0618; Found 248.0620.

Synthesis of N-1-(Ethyloxycarboxymethyl)-S-(2-methoxybenzyl)-2-thiouracil
(11a)
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Under the nitrogen atmosphere, sodium (528 mg, 23 mmol) was added to refluxing
absolute EtOH (40 ml) and was added to a suspension of 10 (5.4 g, 21.9 mmol) in EtOH (25 mL)
and heated to reflux. To the reaction mixture was added ethyl bromoacetate (1.21 mL, 11.4 mmol)
and reflux was continued for 2 h. Ethyl bromoacetate (4 g, 2.6 mL, 23 mmol) was added and reflux
was continued for 4 h. The resulting mixture was cooled to room temperature and EtOH was
removed under reduced pressure. Water (15 mL) was added, and the mixture was extracted with
CH2Cl2 –MeOH (3:1, 60mL) twice. The combined organic layers were dried over anhydrous
sodium sulfate and concentrated in vacuo after filtration. The residue was purified by column
chromatography on silica gel (for 11b hexane-EtOAc = 5:1 to 1:1; for 11a, EtOAc to EtOAcMeOH = 9:1) to afford 11a (2.5 g, 7.4 mmol, 34.1%) as a white solid, 11b (810 mg, 2.42 mmol,
11%) as an oil. 1H NMR (599 MHz, Chloroform-d) δ 7.43 (d, J = 7.6 Hz, 1H), 7.26 – 7.19 (m,
1H), 7.11 (d, J = 7.6 Hz, 1H), 6.89 – 6.80 (m, 2H), 6.03 (dd, J = 7.5, 1.7 Hz, 1H), 4.51 (d, J = 1.7
Hz, 2H), 4.48 (d, J = 1.7 Hz, 2H), 4.20 (q, J = 7.1 Hz, 2H), 3.81 (s, 3H), 1.22 (t, J = 7.1 Hz, 3H);
C }1H} NMR (151 MHz, Chloroform-d) δ 167.8, 165.9, 163.6, 157.6, 143.81, 131.2, 129.3,

13

123.7, 120.6, 110.4, 109.9, 62.5, 55.4, 52.7, 31.3, 13.9. HRMS (ESI/Q-TOF) m/z: [M+H]+ Calcd
for C16H18N2O4S 334.0987; Found 334.0990.

Acidolysis studies of thioesters
A solution of 0.02 mL trifluoroacetic acid, 0.02 mL triethylsilane and 0.96 mL deuterated
chloroform were added to 3 mg of protected thiouracil (6a, 11a) and the reaction was monitored
by 1H NMR at 2 min intervals unit until the reaction was completed (See supporting
information). Integration of benzylic protons was monitored to determine the rate of deprotection.
In order to confirm that acidolysis was complete ESI-MS data was collected. HRMS (ESI/Q-TOF)
m/z: [M+H]+ Calcd for C8H10N2O3S [M+H]+ 214.0412 found 214.0404.
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Synthesis of 2-(2-((4-methoxybenzyl)thio)-4-oxopyrimidin-1(4H)-yl)acetic acid
(12)
To a solution of 6a (1.7 mg, 5 mmol) in a mixture of methanol (10 mL) and tetrahydrofuran
(20 mL) was added 2 M lithium hydroxide (4.3 mL, 8.7 mmol) at room temperature. After stirring
at the same temperature for 30 min, the solvent was removed in vacuo. The residue was dissolved
in 5 mL water and the solution was acidified with 2 M hydrochloric acid. The resulting precipitate
was filtered and washed with cold ethyl acetate and diethyl ether and then dried under a high
vacuum to give 12 (1.25g, 4.1 mmol, 82%) as a white solid. The 1H NMR and 13C NMR spectra
of the product is matched the literature spectra reported by Nielsen et. al.31 1H NMR (400 MHz,
DMSO-d6) δ 7.51 (d, J = 7.5 Hz, 1H), 7.34 (d, J = 8.6 Hz, 2H), 6.87 (d, J = 8.7 Hz, 2H), 5.79 (d,
J = 7.4 Hz, 1H), 4.29 (s, 2H), 4.04 (s, 2H), 3.73 (s, 3H); 13C}1H} NMR (101 MHz, DMSO-d6) δ
168.9, 168.0, 161.6, 159.1, 142.3, 130.9, 128.7, 117.5, 114.4, 55.6, 52.9, 40.6, 40.4, 40.2, 40.0,
39.8, 39.6, 39.4, 34.8.

Synthesis of methyl (2-((((9H-fluoren-9
yl)methoxy)carbonyl)amino)ethyl)glycinate (14)
To liberate the free base of 13 the above HCl salt was dissolved in CHCl3, washed with
saturated aqueous NaHCO3, dried (Na2SO4) and concentrated in vacuo, to give the free base of 14
as a colourless oil. 1H NMR (400 MHz, DMSO-d6) δ 9.07 (brs, 1H), 7.91 (d, J = 7.5 Hz, 2H), 7.69
(d, J = 7.5 Hz, 2H), 7.43 (t, J = 7.5 Hz, 2H), 7.35 (t, J = 7.4 Hz, 2H), 4.37 (d, J = 6.7 Hz, 2H), 4.24
(t, J = 6.7 Hz, 1H), 4.01 (s, 2H), 3.76 (s, 3H), 3.57 (s, 3H), 3.02 (t, J = 6.4 Hz, 2H). 13C}1H} NMR
(100 MHz, DMSO-d6) δ 167.9, 156.7, 144.3, 141.2, 128.1, 127.7, 125.6, 120.6, 66.1, 55.4, 53.0,
47.3, 47.1, 47.1, 40.6, 40.4, 40.2, 40.0, 39.8, 39.6, 39.4, 37.3.
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Synthesis of methyl N-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)ethyl)N-(2-(2-((4-methoxybenzyl)thio)-4-oxopyrimidin-1(4H)-yl)acetyl)glycinate (15)
To a solution of 12 (700 mg, 2.28 mmol) in DMF (10 mL) were added HBTU (872 mg,
2.3 mmol) and DIPEA (674 mL, 3.96 mmol) at 0 °C. After stirring for 10 min, 14 (744.2 mg, 2.1
mmol) was added at the same temperature. The resulting mixture was allowed to warm to room
temperature and stirred for 4 h. The reaction mixture was diluted with EtOAc, poured into water,
and extracted with EtOAc three times. The combined organic layers were washed with 5% sat.
citric acid/H2O (20 mL), saturated aqueous NaHCO3, brine, dried over anhydrous sodium sulfate,
and concentrated in vacuo after filtration. The residue was purified by column chromatography on
silica gel (CH2Cl2-MeOH = 30:1 to 19:1) to afford 15 (912 mg, 1.41 mmol, 69%) as an amorphous
solid. 1H NMR (400 MHz, CDCl3) δ 7.83 – 7.33 (m, 5H), 7.22 – 6.98 (m, 1H), 6.94 – 6.73 (m,
2H), 6.14 – 6.00 (m, 1H), 5.72 (s, 1H), 5.32 (s, 2H), 4.82 – 4.22 (m, 6H), 4.26 – 4.00 (m, 3H), 3.86
– 3.31 (m, 7H); 13C}1H} NMR (101 MHz, CDCl3) δ 19.5, 29.7, 34.96, 35.04, 38.6, 38.8, 39.1,
47.1, 47.2, 47.8, 48.6, 48.9, 49.2, 50.3, 52.2, 55.07, 55.1, 55.8, 66.6, 66.7, 67.5, 68.0, 109.5, 111.2,
111.3, 116.2, 119.9, 120.0, 127.8, 128.3, 128.6, 128.6, 128.7, 128.8, 129.0, 131.8, 134.4, 134.8,
138.9, 141.3, 143.5, 143.8, 144.7, 156.6, 159.4, 163.5, 165.6, 168.3, 168.6, 169.2; HRMS (ESI/QTOF) m/z: [M+Na]+ Calcd for C33H32N4O7SNa 665.2046; Found 665.2050.
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Synthesis of N-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)ethyl)-N-(2-(2((4-methoxybenzyl)thio)-4-oxopyrimidin-1(4H)-yl)acetyl)glycine (16)
To a solution of 15 (570 mg, 0.87 mmol) in 15 mL tetrahydrofuran at 0 °C was added 10
mL 2M lithium hydroxide and solution was stirred for 30 min. The reaction was neutralized with
2 M hydrochloric acid then the solvent was evaporated under reduced pressure. The residue was
suspended in 10 mL cold water with crushed ice and the solid was collected by filtration. The solid
was suspended in cold dichloromethane and produce was collected by filtration, yielding the PNA
monomer (16) as a pure white solid (220 mg, 0.34 mmol, 39%). The 1H NMR and

13

C NMR

spectra of the product is matched the literature spectra reported by by Kittaka et al.41 1H NMR (600
MHz, Methanol-d4) δ 7.78 (t, J = 6.9 Hz, 2H), 7.62 (d, J = 7.4 Hz, 1H), 7.59 – 7.54 (m, 1H), 7.37
(t, J = 7.4 Hz, 2H), 7.29 (t, J = 7.4 Hz, 2H), 7.22 (d, J = 8.2 Hz, 1H), 7.13 (d, J = 8.3 Hz, 1H), 6.71
(d, J = 8.2 Hz, 1H), 6.57 (d, J = 8.2 Hz, 1H), 4.48 – 4.05 (m, 5H), 3.94 (d, J = 12.9 Hz, 2H), 3.66
(s, 2H), 3.56 – 3.51 (m, 2H), 3.47 (qd, J = 9.1, 8.1, 3.8 Hz, 4H), 3.36 – 3.32 (m, 2H).
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C}1H}

NMR (100 MHz, DMSO-d6) δ 170.1, 168.1, 166.8, 162.01, 159.0, 156.5, 144.4, 142.5, 141.1,
130.8, 129.4, 128.8, 128.0, 127.7, 127.6, 125.9, 121.9, 120.5, 117.1, 114.3, 66.0, 55.5, 53.5, 53.0,
48.4, 47.1, 40.6, 40.4, 40.2, 40.0, 39.8, 39.6, 39.4, 38.3, 34.9.; HRMS (ESI/Q-TOF) m/z: [M+Na]+
Calcd for C33H32N4O7SNa 651.1889; Found 651.1909.

SynthesisN-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)ethyl)-N-(2-(4oxo-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)acetyl)glycine (17)
A solution of 16 (120 mg, 0.18 mmol) in 15 mL trifluoroacetic acid and 0.75 mL
triethylsilane was prepared and it was stirred for 30 min. The solvent was then evaporated under a
nitrogen stream and the resulting residue was washed twice with toluene to remove the protecting
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group from the nucleobase, yielding the PNA monomer (17) as a pure white solid (70 mg, 0.38
0.14 mmol, 78%). 1H NMR (400 MHz, DMSO-d6) δ 8.1 (m, 1H), 7.89 (d, J =7.4, 2H), 7.67 (m,
2H), 7.43-7.27 (m, 6H), 4.31 (s, 2H), 4.22 (s, 2H), 3.64 (s, 2H), 3.59 (s, 1H), 3.38 (m, 2H), 3.15
(m, 2H).

13

C}1H} NMR (400 MHz, DMSO) δ 170.2, 168.2, 166.8, 162.0, 156.5, 144.4, 142.5,

141.1, 130.8, 129.4, 128.8, 128.1, 127.8, 127.6, 125.9, 121.9, 120.5, 117.1, 66.0, 53.4, 53.1, 47.2,
38.4, 35.1. HRMS (ESI/Q-TOF) m/z: [M+Na]+ Calcd C25H24N4O6SNa 531.1317; Found
531.1323.

tert-butyl 2,6-bis(bis(tert-butoxycarbonyl)amino)-9H-purine-9-carboxylate
(19)

2,6-Diaminopurine (2 g, 13.32 mmol), Boc2O (19 g, 80 mmol), and DMAP (0.2 g, 2 mmol) were
added to THF (100 mL) at 0 °C. The solution was stirred for 10 min then warmed to room
temperature. After 18 h the solvent was removed. The residue was dissolved in DCM (200 mL)
and washed with H2O (150 mL). The organic layer was dried over Na2SO4 and the solvent was
removed. The residue was purified by column chromatography (EtOAc : Hexanes = 1 : 2) to yield
5 (8.02 g, 96%) as a white foam. Spectroscopic analysis conformed to previous reports42. 1H NMR
(400 MHz, Methylene Chloride-d2) δ 8.60 (s, 1H), 1.73 (s, 9H), 1.48 (s, 18H), 1.45 (s, 18H).
C}1H} NMR (101 MHz, CD2Cl2) δ 153.7, 153.1, 151.6, 150.8, 149.7, 145.6, 144.3, 127.8, 87.3,

13

83.9, 83.3, 53.9, 53.7, 53.4, 53.1, 52.8, 27.5, 27.6, 27.4.

di-tert-butyl (9H-purine-2,6-diyl)bis((tert-butoxycarbonyl)carbamate) (20)
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5 (7.9 g, 14.7 mmol) was suspended in a mixture of MeOH (50 mL) and saturated NaHCO3
solution (25 mL). The turbid solution was heated to 50 °C for 1 h and then cooled to room
temperature. After 18 h the MeOH was removed by rotary evaporation and the solution was diluted
with H2O (100 mL) and extracted with DCM (2 × 100 mL). The combined organic layers were
dried over Na2SO4 and the solvent was removed to yield 6 (5.55 g, 10 mmol, 68% yield) as a white
foam. Spectroscopic analysis conformed to previous reports42. 1H NMR (400 MHz, Methylene
Chloride-d2) δ 8.55 (s, 1H), 1.47 (s, 18H), 1.46 (s, 19H). 13C NMR (101 MHz, CD2Cl2) δ 151.3,
151.0, 150.3, 144.3, 84.4, 83.3, 53.9, 53.6, 53.4, 53.1, 52.9, 27.6, 27.4.

benzyl 2-(2,6-bis(bis(tert-butoxycarbonyl)amino)-9H-purin-9-yl)acetate (21)

6 (5.35 g, 9.7 mmol) and K2CO3 (1.46 g, 10 mmol) were added to DMF (15 mL) at 0 °C. Benzyl
bromoacetate (1.69 mL, 10 mmol) was added dropwise over 10 min. The solution was stirred for
15 min then warmed to room temperature. After 18 h the reaction mixture was diluted with H 2O
(150 mL) and extracted with ether (2 × 100 mL). The organic layers were combined, washed with
water (100 mL), dried over Na2SO4, and the solvent removed to yield 6 (6.5 g, 9.4 mmol 97%
yield) as a white foam. Spectroscopic analysis conformed to previous reports42. 1H NMR (400
MHz, Methylene Chloride-d2) δ 8.23 (s, 1H), 7.41 (dd, J = 2.5, 0.9 Hz, 5H), 5.27 (s, 2H), 5.13 (s,
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2H), 1.45 (s, 18H), 1.44 (s, 18H). 13C}1H} NMR (101 MHz, CD2Cl2) δ 166.7, 154.3, 152.3, 150.8,
150.1, 150.0, 145.9, 128.7, 128.4, 126.6, 83.7, 83.1, 67.9, 44.4, 27.5, 27.4.

2-(2,6-bis(bis(tert-butoxycarbonyl)amino)-9H-purin-9-yl)acetic acid (22)

7 (5.65 g, 8.10 mmol) was dissolved in MeOH (10 mL). Pd/C (100 mg) was added and the reaction
vessel was placed under an atmosphere of H2. The suspension was stirred for 2 h at room
temperature. The suspension was filtered through Celite with MeOH (100 mL) and the solvent
removed to yield 8 (4.9 g, 8.01 mmol, 99% yield) as a glassy grey solid. Spectroscopic analysis
conformed to previous reports42. 1H NMR (400 MHz, DMSO-d6) δ 8.66 (s, 1H), 5.14 (s, 2H), 1.37
(s, 18H), 1.35 (s, 18H). 13C}1H} NMR (101 MHz, DMSO-d6) δ 169.2, 154.6, 151.6, 150.7, 150.1,
148.9, 83.9, 83.4, 40.6, 40.4, 40.2, 39.9, 39.8, 39.5, 39.3, 27.7, 27.6.

benzyl N-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)ethyl)-N-(2-(2,6bis(bis(tert-butoxycarbonyl)amino)-9H-purin-9-yl)acetyl)glycinate (23)
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Fmoc/Bn PNA backbone (1.03 g, 2.39 mmol), 8 (2.78 g, 4.50 mmol), EDC (0.95 g, 6.12 mmol)
and HOBt (0.1 g, 0.67 mmol) were added to DCM (20 mL) at 0 °C. The solution stirred for 20 min
then warmed to room temperature. The reaction was monitored by TLC. Upon completion, the
reaction mixture was diluted with DCM (100 mL) and washed against a mixture of a saturated
NaHCO3 solution (50 mL) and brine (100 mL). The organic layer was dried over Na2SO4,
and the solvent removed. The residue was subjected to FCC (EtOAc : hexane = 2 : 1 to 1 : 0) to
yield 9 (1.72 g, 1.69 mmol 71% yield) as a white powder. Spectroscopic analysis conformed to
previous reports42. 1H NMR (400 MHz, DMSO-d6) δ 7.93 – 7.85 (m, 2H), 7.65 (m, J = 16.5, 7.4,
4.5, 2.6 Hz, 2H), 7.44 – 7.24 (m, 9H), 5.42 – 5.11 (m, 3H), 4.36 – 4.16 (m, 3H), 3.72 (s, 1H), 3.62
– 3.57 (m, 1H), 2.39 – 2.09 (m, 2H), 1.43 – 1.33 (m, 36H). 13C}1H} NMR (101 MHz, DMSO-d6)
δ 168.4, 167.8, 154.5, 151.6, 150.7, 150.1, 150.0, 148.7, 144.3, 141.2, 128.9, 128.8, 128.3, 128.3,
128.0, 127.5, 126.4, 125.6, 125.5, 120.5, 84.0, 83.4, 67.3, 65.8, 53.0, 47.1, 46.9, 44.9, 40.6, 40.4,
40.2, 40.0, 39.7, 39.5, 39.3, 32.7, 27.6, 27.5, 20.3.

N-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)ethyl)-N-(2-(2,6bis(bis(tert-butoxycarbonyl)amino)-9H-purin-9-yl)acetyl)glycine (24)

9 (1.71 g, 1.67 mmol) was dissolved in MeOH (20 mL) and Pd/C (70 mg) was added. The reaction
vessel was placed under an atmosphere of H2. The suspension was stirred for 3 h at room
temperature. The reaction was filtered through Celite with MeOH (100 mL) and the solvent
removed to yield 10 (1.52 g, 1.61 mmol, 96% yield) as a flaky white solid. Spectroscopic analysis
conformed to previous reports42. 1H NMR (400 MHz, Methanol-d4) δ 8.55 (s, 1H), 7.75 (dd, J =
16.7, 7.6 Hz, 2H), 7.64 (q, J = 7.3, 5.4 Hz, 2H), 7.47 – 7.21 (m, 4H), 5.36 (s, 1H), 5.22 (s, 1H),
4.87 (s, 2H), 4.60 – 4.09 (m, 3H), 3.77 (s, 1H), 3.67 – 3.44 (m, 2H), 3.31 (d, J = 6.6 Hz, 1H), 1.42
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(d, J = 6.6 Hz, 36H). 13C}1H} NMR (101 MHz, Methanol-d4) δ 171.1, 169.1, 167.7, 157.3, 154.5,
151.8, 150.8, 150.3, 150.0, 148.1, 143.8, 141.2, 128.3, 128.3, 127.5, 126.9, 124.9, 124.8, 119.7,
84.0, 83.5, 66.3, 52.1, 48.6, 48.4, 48.2, 48.0, 44.4, 44.1, 26.8, 26.7.

General procedure for acidolysis studies of thioesters. To a solution of 0.02 mL
trifluoroacetic acid, 0.02 mL triethylsilane and 0.96 mL deuterated chloroform was added to 3 mg
of protected thiouracil compound and the reaction was monitored by 1H NMR at 2 min. intervals
until the reaction was completed. The reaction was carried out at 25 °C and monitored for 2 h, or
until reaction had gone to completion. Integration of benzylic protons was monitored to determine
the rate of deprotection.

Oligomer synthesis. PNA oligomers were synthesized using the ABI 433A peptide
synthesizer using manufacturer supplied “Fastmoc” cycles. Oligomerization was carried out using
newly synthesized SU or ST monomers and commercially available Fmoc-A(Bhoc)-AEG-OH,
Fmoc-G(Bhoc)-AEG-OH, and Fmoc-C(Bhoc)-AEG-OH, Fmoc-T(Bhoc)-AEG-OH (purchased
from PolyOrg, Inc.), and Nα-Fmoc-Nε-Boc-L-lysine (Chem-Impex International Inc.).
FmocRAM-PS was used as a solid support resin preloaded with L-lysine at 0.057 mmol/g. The
synthesis was carried out on a 5.0 µmol scale. The synthesis cycle was only modified by using
20% 4-methylpiperidine in dimethylformamide for Fmoc deprotection.29 Following automated
synthesis, the resin was treated with a solution of 95% trifluoroacetic acid and 5% triethylsilane to
cleave the oligomer from the resin and remove the protecting group from the nucleobases (Bhoc)
and amino group (Boc). The solvent was then evaporated under a nitrogen stream, the resulting
residue was washed twice with cold ether, dissolved in a solution of 0.05% trifluoroacetic acid in
water then purified by reverse-phase HPLC. Reverse-phase HPLC was performed on an Agilent
MicrosorbMV 100-5 C18 250 × 4.6 mm column heated to 50 °C. The purified PNA oligomer was
eluted using a gradient (water/0.1% trifluoroacetic acid to acetonitrile/0.1% trifluoroacetic acid)
over 60 min.
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Thermal stability analysis. Thermal stabilities (Tm) of complexes were measured in
solutions of 100 mM NaCl, 10 mM sodium hydrogen phosphate, 0.1 mM EDTA, pH=7.0 with
individual PNA strand concentrations of 2 µM. Absorbance at λ = 260 nm was measured at 0.5 °C
intervals while the temperature was changed at a rate of 0.7 °C/min between 15-90 °C. Tm values
were measured in triplicate and determined by the first derivative method applied through the
manufacturer supplied Varian WinUV Bio software.

Computations. Structures were constructed and minimized in Spartan ’14 using a desktop
computer at the Hartree Foch 6-31G* level. A computational search for low energy conformers
was performed using the same basis set. A variety of trials were run wherein the initial dihedral
angle of C2-S-CH2-Ph bond was set to avoid starting with the 2-methoxy group interacting with
the protonated N3. The model nucleobase protected with 3-methoxybenzyl- or 4 methoxybenzyl
protecting groups were similarly modeled and subjected to equilibrium conformer search for
comparison.

49

References
(1)

Hyrup, B.; Nielsen, P. E. Peptide Nucleic Acids (PNA): Synthesis, Properties and
Potential Applications. Bioorganic Med. Chem. 1996, 4 (1), 5–23.

(2)

Lohse, J.; Dahl, O.; Nielsen, P. E. Double Duplex Invasion by Peptide Nucleic Acid: A
General Principle for Sequence-Specific Targeting of Double-Stranded DNA. Proc. Natl.
Acad. Sci. 1999, 96, 11804–11808.

(3)

Hepler, L. G. Effects of Substituents on Acidities of Organic Acids in Water:
Thermodynamic Theory of the Hammett Equation. J. Am. Chem. Soc. 1963, 85 (20),
3089–3092.

(4)

Bialy, L.; Díaz-Mochón, J. J.; Specker, E.; Keinicke, L.; Bradley, M. Dde-Protected PNA
Monomers, Orthogonal to Fmoc, for the Synthesis of PNA-Peptide Conjugates.
Tetrahedron, 2005, 61 (34), 8295–8305.

(5)

Giorgio, C. Di; Palrot, S.; Schwergold, C.; Patino, N.; Condom, R.; Giorgio, A. F.; Guedj,
R. O. Tetrahedron 1999, 55, 1937–1958.

(6)

Zinieris, N.; Leondiadis, L.; Ferderigos, N. N??-Fmoc Removal from Resin-Bound Amino
Acids by 5% Piperidine Solution. J. Comb. Chem. 2005, 7 (1), 4–6.

(7)

Hachmann, J.; Lebl, M. Alternative to Piperidine in Fmoc Solid-Phase Synthesis. J.
Comb. Chem. 2006, 8 (2), 149.

(8)

St. Amant, A. H.; Hudson, R. H. E. Synthesis and Oligomerization of Fmoc/Boc-Protected
PNA Monomers of 2,6-Diaminopurine, 2-Aminopurine and Thymine. Org. Biomol.
Chem. 2012, 10 (4), 876–881.

(9)

Rouhi, Atefeh, "Synthesis and Photophysical Studies of Pyrrolocytosine Derivatives"
(2017). Electronic Thesis and Dissertation Repository. 5020.

(10)

Jansen, K.; Richelson, E. Detection of Peptide Nucleic Acids in Tissue Extracts of Treated
Animals by Gel Mobility Shift Assay. J. Biochem. Biophys. Methods 2000, 42 (1–2), 31–
34.

(11) Hudson, R. H. E.; Ghorbani-Choghamarani, A. Selective Fluorometric Detection of
Guanosine-Containing Sequences by 6-Phenylpyrrolocytidine in DNA. Synlett 2007, 2007
(06), 870–873.
(12)

Sugiyama, T.; Hasegawa, G.; Niikura, C.; Kuwata, K.; Imamura, Y.; Demizu, Y.;
Kurihara, M.; Kittaka, A. PNA Monomers Fully Compatible with Standard Fmoc-Based
Solid-Phase Synthesis of Pseudocomplementary PNA. Bioorganic Med. Chem. Lett. 2017,
27 (15), 3337–3341.

50

Chapter 3
Modified fluorescent dihydroquinazolinone/ quinazolinone
heterocyclic frameworks based on uracil scaffold

3.1 Introduction
Fluorescent nucleobase analogues are chemically modified nucleobases which are able to
maintain their chemical and biological functional properties. This includes base stacking and base
pairing. As a result of their usefulness, these molecules have become an incredibly important tool
within chemistry and biology as they inform the molecular-level comprehension of nucleic acid
structures as well as their locations and interactions.1 In 1969, Stryer reported a class of emissive
compounds including formycin and 2-aminopurine (2AP)2. This study showed that fluorescent
analogues can indeed facilitate studies of nucleic acids conformation and interactions. The study
has led to further work and the creation of a variety of fluorescent nucleobases. As natural
nucleobases are generally non-fluorescent, significant modifications to their structure is essential
before they can be useful as an emissive tools. These types of chemical modifications can either
be made with an eye to preserving Watson–Crick base-pairing ability (that is, retaining ‘canonical’
pairing), or more dramatic changes to the nucleobase architecture can be made, resulting in noncanonical designs.1
The basic requirements that are imposed upon new the nucleobase fluorophore analogue
synthesis includes the following: (a) to maintain the structural similarity to the canonical
nucleobases; (b) to display emission at long wavelengths; (c) to retain sufficient emission quantum
efficiency to be utilized in real time fluorescence-based assays; and, importantly, (d) to show the
sensitivity to different environments that is manifested in markedly different photophysical
parameters in different environment. Thus, fluorescent nucleobase analogues that respond to
changes in their microenvironment are valuable for studying nucleic acid structure, dynamics, and
recognition.1 Here we describe the synthesis of a quinazolinone-based uracil scaffold (Scheme
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3.1) as well as their basic photophysical characteristics. We demonstrate that the molecular rigidity
plays a key role in the fluorescent property of quinazolinone-based uracil scaffold as a fluorescent
PNA probe by generating higher quantum yields in lower temperatures or a more viscous solvent.
Furthermore, we studied the effect of electron-donating and electron-withdrawing groups on the
fluorescent response of the quinazolinone-based uracil scaffold compounds. An advantage of this
molecular system is the ease of synthesis from readily available and inexpensive starting materials
(Scheme 3.1).

Scheme 3.1 Retro-synthesis of quinazolinone uracil-based scaffolds

3.2 Synthesis of quinazolinone-based uracil scaffold as a PNA
monomer
The synthesis of the quinazolinone-based PNA monomer is illustrated in Scheme 3.2
starting with the synthesis of 5-formyluracil (25) from 5-hydroxymethyl uracil according to the
standard chemistry tested in Hudson’s group. In the next step, 5-formyluracil (25) was condensed
with ethyl bromoacetate in basic DMF to do the N1 alkylation.
In order to test the effect of electron-withdrawing and electron-donating groups on the fluorescent
properties of quinazolinone and dihydroquinazolinone compounds, methoxy and nitro 2-amino
benzamide compounds were synthesized from 2-amino benzoic acid compounds by following the
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reported patent43. In order to increase the yield of these reactions, triphosgene was used (instead
of phosgene) and isatoic anhydride intermediate compound collected at room temperature and then
amination with liquid ammonia was done and reactions kept in lower temperatures. In the next
step, 5-formyluracil was condensed with different 2-aminobenzamide compounds using copper
(II) nitrate as a catalyst to give substituted dihydroquinazolinone compounds.

Scheme 3.2. Synthesis of modified quinazolinone based uracil scaffold tert-butyl- acetate
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3.3 Approaches for the synthesis of quinazolinones
Substituted quinazolinones have been synthesized by a number of methods involving
several substrates such as 2-aminobenzaldehyde and 2-aminobenzoketones or 2-amino-N
arylbenzamidines or 2-halophenylmethanamines44. The condensation of 2-aminobenzylamines
with aldehydes using copper (II) nitrate in refluxed ethanol followed by subsequent oxidation with
strong oxidants such as 2,3-dichloro-5,6-dicyano-l,4-benzoquinone (DDQ), MnO2 and NaClO
provides a conventional but simple method to synthesize quinazolinones45. However, despite the
synthetic usefulness of this approach, the reported oxidizing conditions suffer from the drawbacks
that a stoichiometric amount of nonrenewable oxidant has to be used and the yields are not
satisfactory. Therefore, more efficient and environmentally friendly catalytic systems are needed
to render this method to be synthetically more attractive.
So, we tested different facile and efficient approach for the aerobic oxidative synthesis of
substituted dihydroquinazolinones and by using a one-pot reaction of aldehydes with 2aminobenzylamines and CuCl/DABCO/4-HO-TEMPO as the catalysts under mild conditions
(Scheme 3.3.). The copper/N-ligand/TEMPO catalytic system has been proven to be a powerful
promoter for the aerobic oxidation of primary alcohols46,47, but its applications in the oxidative
dehydrogenation synthesis of nucleobase scaffold heterocycles of have not been reported yet. This
work provides the first example toward this goal.
The study was initiated by conducting the reaction of anthranilamide (1 equiv) with N1-alkylated5-formyluracil 26 (1 equiv). First, the two starting materials were allowed to condense in situ; then
4-HO-TEMPO 4 (0.2 equiv) was added as the catalyst and the reaction system was charged with
an oxygen balloon. As expected, the target molecule 36 was obtained, but the yield was poor due
to the oxidative decomposition of dihydroquinazolinone intermediate (Table 3.1, entry 1).
To improve the yield, copper salts were employed together with TEMPO to catalyze the reaction.
The catalytic systems based on copper and TEMPO has proved to be very effective for the aerobic
oxidation of alcohols45. We hoped that these systems might work equally well to affect the
dehydrogenation of dihydroquinazolinone compounds. To our delight, the reaction did improve
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when CuCl was used, and the yield of 36 was raised up to 43% (Table 2.1, entry 3). The yield of
the reaction was further improved by the addition of monodentate N-containing ligands such as
Et3N, DABCO (1,4-diazabicyclo[2.2.2]octane), and DMAP (N,N-dimethylpyridin-4-amine)
(Table 3.1., entries 4-8)

Scheme 3.3. CuCl/DABCO/TEMPO-catalyzed one-pot aerobic oxidative synthesis of
modified quinazolinones

entry

copper

ligand

TEMPO

solvent

yield (%)

4-HO

toluene

32

1
2

CuBr

4-HO

DMF

22

3

CuCl

4-HO

DMF

43

4

CuCl

Et3N

4-HO

CH3CN

62

5

CuCl

Et3N

4-HO

CH3CN

80

6

CuCl

DMAP

4-HO

DMSO

86

7

CuCl

DABCO

4-HO

DMSO

12b

8

CuCl

DABCO

4-HO

DMSO

96

Table 3.1. Optimization on the Catalytic Aerobic Oxidative Synthesis of Quinazolinonea

a

Anthranilamide (1 mmol) and alkylated formyluracil (1 mmol) were dissolved in solvent (8 mL) in a 25

mL flask, and the mixture was stirred at 80 °C until the condensation completed (about 2 h). Then copper
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salts (0.025 mmol), DABCO (0.022 mmol), and TEMPO (0.012 mmol) were added to the reaction
mixture and stirring was continued at 80 °C under oxygen until anthranilamide was consumed completely
as monitored by TLC.
b

Under nitrogen.

3.4 Photophysical properties
UV-Vis spectra and fluorescence studies of 31 to 40 have been investigated in order to
calculate the molar absorbance coefficient (Ɛ) and quantum yield (Φ) under different solvents
(Table 3.2). The values indicate that generally, the quantum yield in ethanol is greater than the
other solvents for dihydroquinazolinone compounds.

𝑳

Compound #

Φ (EtOH)

Φ (DMSO)

Φ (THF)

λmax (nm)

Ɛ (𝒎𝒐𝒍.𝐜𝒎)c

31

0.015

0.002

0.001

341

Ɛ 341 =67970

32b

0.008

0.003

0.001

417

Ɛ 417 =65500

33b

0.007

0.001

0.001

417

Ɛ 417 =65430

34

0.014

0.003

0.003

321

Ɛ 325 =39220

35

0.019

0.004

0.003

321

Ɛ 325 =39120

Table 3.2. Photophysical properties a of dihydroquinazolinone compounds 31-35
a

The quantum yields were determined using emission wavelengths range between 340 and 640 nm with

an excitation wavelength of 325 nm.
b

Excitation wavelength at 310 nm.

c

Calculated based on absorption in DMSO.
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Molecular structure plays a major role in determining fluorescence parameters of aromatic
molecules. Nonplanar molecules usually have structureless absorption and fluorescence spectra
while planar and rigid molecules of the high-symmetry group show absorption and fluorescence
spectra with well-resolved vibrational bands48. Prior to 1970, it was believed that the ability of
some molecules to emit fluorescence radiation was totally attributable to molecular rigidity.
Berlman49, however, showed later that rigidity in the So state was not as important a factor as
rigidity in the first excited S1 excited state, that is, in maintaining a planar or near planar
configuration. Currently, there is no doubt that the planarity and rigidity of a molecule play
important roles in determining the fluorescence parameters of a compound. Thus, the
dehydrogenation of dihydroquinazolinone compounds 31-35 (Scheme 3.1.) was done to add a π
bond and make the molecule more rigid around the linker bond on the 5-position of uracil. This
will fix the uracil and quinazolinone moiety in the same plane (Figure 3.1. a and b) and eventually
increase the fluorescence quantum yield. Also, it may be further rigidified by an intramolecular
hydrogen bond between the oxygen in the carbonyl group at 4-position of uracil and amide in
heterocycle ring. (Figure 3.1) Moreover, in order to show the effect of molecular rigidity on
fluorescent properties, the quantum yield calculation was done in three different temperatures and
glycerol as a more viscous solvent. (Table 3.3.).
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(a)

(b)

Figure 3.1. 3D Molecular structure at minimum energy statea of modified
dihydroquinazolinone (a) and quinazolinone (b) compounds.
a

Using energy minimization in MM2 calculation by Chem3D software.
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Compound #

36

𝑳

Φ (EtOH)

Φ (DMSO)

Φ (THF)

Φ (Glycerol)

λmax (nm)

Ɛ (𝒎𝒐𝒍.𝒄𝒎)c

T (°C)

0.012

0.006

0.008

0.083

331

Ɛ 331 = 36391

23

0.006

0.002

0.031

60

0.038

15
0.003

37b

NA*

0.004

0.024

417

Ɛ 417 = 65499

0.001

23
60
15

0.001
38b

NA*

0.003

0.018

417

Ɛ 417 = 65532

<0.001

23
60
15

39

0.023

0.009

0.006

0.007

0.016

0.076

340

Ɛ 340 = 39120

0.059

60

0.041

40

23

15

0.035

0.011

0.017

0.008

0.019

0.106

340

Ɛ 340 = 39042

0.062

0.076

23
60
15

Table 3.3. Photophysical properties a of quinazolinone compounds 36-40.
*

Compound was not soluble in ethanol

a

The quantum yields were determined using emission wavelengths range between 340 and 640 nm with

an excitation wavelength of 330 nm.
b

Excitation wavelength at 310 nm.

c

Calculated based on absorption in DMSO

Based on the values from (Table 3.3.) quinazolinone compounds (36-40) show greater
quantum yields than dihydroquinazolinones 31-35, however, the solubility of these compounds is
weaker and in some cases insoluble in organic solvents. Also, it shows that by using a more viscous
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solvent (glycerol) or in lower temperature the quantum yield will be stronger by making the
fluorescence molecule more rigid, which explains the aforementioned rotation around nucleobase
linker (Figure 3.1.).
These quinazolinone based uracil scaffolds can bind to DNA and RNA through base pairs and
making the DNA duplex more stable as a fluorescent molecule. In order to study the effect of
electron-donating and electron-withdrawing groups on the fluorescent properties in oligomer level
as well as stabilization effect upon hybridization to complementary DNA oligomers, compound
37 and 40 were chosen to make PNA monomers and oligomerization. (Scheme 3.4).
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Scheme 3.4. Synthesis of quinazolinone based uracil scaffold PNA monomer
The tert-butyl-Fmoc-based aminoethylglycine backbone was synthesized as a
hydrochloride salt in by using ethyl diamine followed by adding Fmoc-OSu and DIEA and stored
in the freezer as a hydrochloride salt. The hydrochloride salt backbone was extracted in
dichloromethane to yield 43 as a clear and colourless oil.
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The tert-butyl alkylacetate of the quinazolinone based uracil scaffolds was hydrolyzed
using trifluoroacetic acid, to obtain the carboxylic acid functional group for attachment to the
aminoethylglycine backbone. The quinazolinone based nucleobase was then reacted with a
solution of hydroxybenzotriazole (HOBt), dicyclohexylcarbodiimide (DCC) which act as the
coupling agents, and 4-dimethylaminopyridine (DMAP) which acts as the base. The activated
nucleobase is then reacted with the protected aminoethylglycine (43) backbone to form the PNA
monomer. The tert-butyl ester protecting the C-terminus of the PNA monomer is then hydrolyzed
using trifluoroacetic acid solution to form the C- terminus carboxylic acid.
After C-terminus ester hydrolysis, which gives desired PNA monomer, the oligomerization
can be done. The monomers were characterized using 1H NMR and 13C NMR spectroscopy as well
as high-resolution mass spectrometry (HRMS). 1H NMR spectra show several rotamer structures
(see supplemental data).

3.5 Conclusion
We synthesized PNA monomers carrying quinazolinone moiety and characterized them
by their fluorescence quantum yield response in different solvents and three different temperatures
which shows promising result that may be used as a reporter in PNA probes with expected
stabilization of the formed duplex structure. It was found that emission of quinazolinone based
uracil analogues is sensitive to the rigidity of the molecule which indicates that PNA probe
containing quinazolinone moiety may be a good candidate for reporting binding events by showing
“ON-OFF” fluorescence upon hybridization to complementary oligomers.

3.6 Future work
Incorporation of quinazolinone-based PNA monomer into PNA oligomer is underway.
PNA sequences H-GTAGAXCACT-Lys-NH2 (X= 48 or 49) have been synthesized and their
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thermal melting point and fluorescent response upon hybridization with complementary DNA
sequences will be studied. The ability of these PNA oligomers to be used as a reporter probe will
be evaluated.

3.6 Experimental Procedure

5-formyluracil (25)

Hydroxymethyluracil (4.0 g, 28 mmol), was dissolved in 100 mL water by heating to 75 °C. Then
the solution was cooled down to 40 °C. K2S2O8 (13.6 g, 49.6 mmol) and AgNO3 (0.14 g, 0.8 mmol)
were added and the product began to slowly precipitate. The reaction was stirred for 15 min at 35
°

C and 10 min at room temperature. The suspension was then placed at 4 °C for 1 h. the product

was collected by filtration, washed with cold water and dried to yield 2 (3.2 g, 22.7 mmol, 84%)
as a white solid. Spectra matched those reported by Integrated Spectral Database System of
Organic Compounds with data that were obtained from the National Institute of Advanced
Industrial Science and Technology (Japan).
11.50 (s, 1H), 9.74 (s, 1H), 8.13 (s, 1H).

13

1

H NMR (400 MHz, DMSO-d6) δ 11.96 (s, 1H),

C}1H} NMR (101 MHz, DMSO-d6) δ 186.9, 162.9,

150.9, 149.7, 110.6.
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tert-Butyl (uracil-5-formaldehyde-1-yl) acetate (26)

5-formyluracil (2.0 g, 14.28 mmol) was dissolved in 50 mL added to dry DMF and heated to 40
°

C to dissolve and cooled down to room temperature. Et3N (2 mL, 14.28 mmol) was added to the

solution. tert-Butyl bromoacetate (2.11 ml, 14.28 mmol) was added drop wisely to the stirred
mixture within 30 min and stirring was continued for 24 h under N2 atmosphere. The solvent was
removed in vacuo and the residue was extracted with ethyl acetate and water. The organic layer
was washed with brine, dried by Na2SO4 and concentrated in vacuo to give 7 as a pure white solid
product (3.16 g, 12.43 mmol, 87%). Spectroscopic analysis conformed to previous reports.

1

H

NMR (400 MHz, DMSO-d6) δ 11.92 (s, 1H), 9.79 (s, 1H), 8.51 (s, 1H), 4.56 (s, 2H), 4.02 (q, J =
7.1 Hz, 1H), 1.98 (s, 1H), 1.42 (s, 12H).

13

C}1H} NMR (101 MHz, DMSO-d6) δ 186.8, 167.0,

164.1, 163.7, 162.7, 154.1, 152.4, 150.4, 110.7, 102.6, 82.8, 60.3, 50.5, 50.4, 28.0, 27.9, 14.5.

Synthesis of -nitro and -methoxy benzamide compounds
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2-Amino-5-methoxybenzamide (27)

2-amino-5-methoxybenzoic acid (0.350 g, 2.5 mmol) dissolved in 4 mL THF, heated to 60 °C,
triphosgene (0.25 g, 0.8 mmol) added and stirred for 10 h and checked by TLC. The solution
cooled down to room temperature the isatoic anhydride intermediate filtered and collected. Cold
1N ammonia added to the collected intermediate and stirred for 24 h at 4 °C and checked by TLC.
The crude solution was taken up in 10 ml EtOAc/Hexanes (1:1) mixture and the resulting
precipitate filtered and washed with water and ether to give (0.240 g 1.4 mmol, 58%) of compound
2 as a brown solid. Spectra matched those reported by Integrated Spectral Database System of
Organic Compounds with data that were obtained from the National Institute of Advanced
Industrial Science and Technology (Japan). 1H NMR (400 MHz, DMSO-d6) δ 7.75 (s, 1H), 7.10
(d, J = 2.9 Hz, 1H), 7.08 (s, 1H), 6.84 (dd, J = 8.9, 2.9 Hz, 1H), 6.64 (d, J = 8.9 Hz, 1H), 6.12 (s,
2H), 3.68 (s, 3H). 13C}1H} NMR (101 MHz, DMSO-d6) δ 171.4, 149.6, 144.9, 120.3, 118.2, 114.4,
112.9, 56.0.

2-Amino-5-nitrobenzamide (28)

2-amino-5-nitrobenzoic acid (0.785 g, 4.5 mmol) dissolved in 10 mL THF, heated to 60 °C,
triphosgene (0.45 g, 1.5 mmol) added and stirred for 10 h and checked by TLC. The solution
cooled down to room temperature the isatoic anhydride intermediate filtered and collected. Cold
1N ammonia added to the collected intermediate and stirred for 24 h at 4 °C and checked by TLC.
The turbid solution was filtered and washed with water and ether to give (0.430 g, 2.3 mmol, 48%)
of compound 2 as a yellow solid. Spectra matched those reported by Integrated Spectral Database
System of Organic Compounds with data that were obtained from the National Institute of
Advanced Industrial Science and Technology (Japan). 1H NMR (400 MHz, DMSO-d6) δ 8.56 (d,
J = 2.6 Hz, 1H), 8.21 (s, 1H), 8.02 (dd, J = 9.2, 2.6 Hz, 1H), 7.90 (s, 2H), 7.41 (s, 1H), 6.80 (d, J
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= 9.2 Hz, 1H). 13C}1H} NMR (101 MHz, DMSO-d6) δ 170.1, 156.2, 135.2, 128.0, 126.9, 116.4,
112.5.

2-Amino-4-methoxybenzamide (29)

2-amino-4-methoxybenzoic acid (0.501 g, 3 mmol) dissolved in 6 mL THF, heated to 60 °C,
triphosgene (0.3 g, 1 mmol) added and stirred for 10 h and checked by TLC. Cold 1N ammonia
added to the collected intermediate and stirred for 24 h at 4 °C and checked by TLC. The turbid
solution was filtered and washed with water and ether to give 0.250 g (1.5 mmol, 50%) of
compound 2 as a white solid. Spectra matched those reported by Integrated Spectral Database
System of Organic Compounds with data that were obtained from the National Institute of
Advanced Industrial Science and Technology (Japan). 1H NMR (400 MHz, DMSO-d6) δ 7.49 (d,
J = 8.8 Hz, 1H), 6.74 (s, 2H), 6.20 (d, J = 2.6 Hz, 1H), 6.07 (dd, J = 8.8, 2.6 Hz, 1H), 3.70 (s, 3H).

2-Amino-4-nitrobenzamide (30)

2-amino-4-nitrobenzoic acid (0.549 g, 3 mmol) dissolved in 6 mL THF, heated to 60 °C,
triphosgene (0.3 g, 1 mmol) added and stirred for 5 h and checked by TLC. The solution cooled
down to room temperature and THF removed under reduced pressure. The solution cooled down
to room temperature the isatoic anhydride intermediate filtered and collected. Cold 1N ammonia
added to the collected intermediate and stirred for 24 h at 4 °C and checked by TLC. The turbid
solution was filtered and washed with water and ether to give (0.430 g 2.3 mmol, 80%) of
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compound 2 as an orange solid. Spectra matched those reported by Integrated Spectral Database
System of Organic Compounds with data that were obtained from the National Institute of
Advanced Industrial Science and Technology (Japan).

1

H NMR (400 MHz, DMSO-d6) δ 8.03 (s,

1H), 7.74 (d, J = 8.6 Hz, 1H), 7.57 (d, J = 2.4 Hz, 1H), 7.46 (s, 1H), 7.25 (dd, J = 8.6, 2.4 Hz, 1H),
7.02 (s, 2H).

tert-butyl 2-(2,4-dioxo-5-(4-oxo-1,2,3,4-tetrahydroquinazolin-2-yl)-3,4dihydropyrimidin-1(2H)-yl)acetate (31)

0.50 g (2 mmol) of 7 dissolved in 10 ml reflux ethanol, 36 mg (0.13 mmol) of
Cu(NO3)2.3H2O and 0.14 g (1 mmol) of 2-amino benzamide added to the solution and reaction
mixture stirred for 2 h and checked by TLC, solution cooled down to room temperature and the
resulting precipitate filtered and washed with EtOH and MeOH to give 8 (0.298 g, 0.8 mmol, 80%)
as a white solid. 1H NMR (400 MHz, DMSO-d6) δ 11.62 (s, 1H), 7.95 (d, J = 1.8 Hz, 1H), 7.82 (s,
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1H), 7.62 (dd, J = 7.8, 1.6 Hz, 1H), 7.25 (ddd, J = 8.5, 7.2, 1.7 Hz, 1H), 6.78 (d, J = 8.1 Hz, 1H),
6.75 – 6.66 (m, 2H), 5.68 (d, J = 2.0 Hz, 1H), 4.48 (s, 2H), 1.40 (s, 9H). 13C}1H} NMR (101 MHz,
DMSO-d6) δ 167.5, 163.9, 163.3, 150.9, 148.2, 144.5, 133.7, 127.9, 117.9, 115.3, 112.9, 82.2,
60.4, 50.1, 28.1. HRMS (ESI/Q-TOF) m/z: [M]+ Calcd for C18H20N4O5 372.1434; Found
372.1428.

tert-butyl 2-(5-(6-nitro-4-oxo-1,2,3,4-tetrahydroquinazolin-2-yl)-2,4dioxo-3,4-dihydropyrimidin-1(2H)-yl) acetate (32)

0.50 g (2 mmol) of 7 dissolved in 10 ml reflux ethanol, 36.2 mg (0.15 mmol) of
Cu(NO3)2.3H2O and 0.18 g (1 mmol) of 2-amino-5-nitrobenzamide added to the solution and
reaction mixture stirred for 2 h and checked by TLC, solution cooled down to room temperature
and the resulting precipitate filtered and washed with EtOH and MeOH to give 8 (176 mg, 0.42
mmol, 42%) as a yellow solid. 1H NMR (400 MHz, DMSO-d6) δ 11.67 (s, 1H), 8.41 (dd, J = 8.3,
2.4 Hz, 2H), 8.30 (s, 1H), 8.09 (dd, J = 9.1, 2.8 Hz, 1H), 7.81 (s, 1H), 6.84 (d, J = 9.1 Hz, 1H),
5.85 (t, J = 2.1 Hz, 1H), 4.47 (s, 2H), 1.39 (s, 9H). 13C}1H} NMR (101 MHz, DMSO-d6) δ 167.7,
162.9, 161.6, 152.4, 150.9, 144.4, 137.5, 129.2, 124.5, 114.9, 113.0, 112.9, 82.3, 61.0, 49.9, 28.1.
HRMS (ESI/Q-TOF) m/z: [M]+ Calcd for C18H19N5O7 417.1284; Found 417.1271.
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tert-butyl

2-(5-(7-nitro-4-oxo-1,2,3,4-tetrahydroquinazolin-2-yl)-2,4-

dioxo-3,4-dihydropyrimidin-1(2H)-yl) acetate (33)

0.50 g (2 mmol) of 7 dissolved in 10 ml reflux ethanol, 36.2 mg (0.15 mmol) of Cu(NO3)2.3H2O
and 0.18 g (1 mmol) of 2-amino-5-nitrobenzamide added to the solution and reaction mixture
stirred for 2 h and checked by TLC, solution cooled down to room temperature and the resulting
precipitate filtered and washed with EtOH and MeOH to give 8 (160 mg, 0.38 mmol, 38%) as a
yellow solid. 1H NMR (600 MHz, DMSO-d6) δ 11.62 (s, 1H), 8.34 (s, 1H), 7.79 (d, J = 8.5 Hz,
1H), 7.74 (s, 1H), 7.59 (d, J = 2.3 Hz, 1H), 7.43 – 7.37 (m, 2H), 5.73 (s, 1H), 4.43 (s, 2H), 1.34 (s,
9H).

13

C}1H} NMR (101 MHz, DMSO-d6) δ 166.5, 162.9, 161.6, 152.4, 150.9, 144.4, 137.5,

129.2, 124.5, 114.8, 113.0, 112.9, 82.3, 61.0, 49.9, 27.3. HRMS (ESI/Q-TOF) m/z: [M]+ Calcd for
C18H19N5O7 417.1284; Found 417.1270

tert-butyl 2-(5-(7-methoxy-4-oxo-1,2,3,4-tetrahydroquinazolin-2-yl)-2,4-dioxo3,4-dihydropyrimidin-1(2H)-yl) acetate (34)

69

0.25 g (1 mmol) of 7 dissolved in 10 ml reflux ethanol, 18.1 mg (0.075 mmol) of Cu(NO3)2.3H2O
and 83 mg (0.5 mmol) of 2-amino-4-methoxybenzamide added to the solution and reaction mixture
stirred for 10 h and checked by TLC, solution cooled down to room temperature and the resulting
precipitate filtered and washed with EtOH and MeOH to give 8 (51 mg, 0.13 mmol, 13%) as a
yellow solid. 1H NMR (400 MHz, DMSO-d6) δ 12.37 (s, 1H), 12.03 (s, 1H), 9.02 (s, 1H), 8.02 (d,
J = 8.7 Hz, 1H), 7.12 – 7.01 (m, 2H), 4.70 (s, 2H), 3.89 (s, 3H), 1.45 (s, 9H). 13C}1H} NMR (101
MHz, DMSO-d6) δ 167.2, 164.6, 164.5, 160.1, 151.3, 150.7, 150.1, 149.6, 128.1, 116.1, 114.8,
108.2, 103.2, 82.7, 56.1, 50.7, 28.1. HRMS (ESI/Q-TOF) m/z: [M]+ Calcd for C19H22N4O6
402.1539; Found 402.1536

tert-butyl 2-(5-(6-methoxy-4-oxo-1,2,3,4-tetrahydroquinazolin-2-yl)-2,4-dioxo3,4-dihydropyrimidin-1(2H)-yl) acetate (35)

0.25 g (1 mmol) of 7 dissolved in 10 ml reflux ethanol, 18.1 mg (0.075 mmol) of Cu(NO3)2.3H2O
and 83 mg (0.5 mmol) of 2-amino-5-methoxybenzamide added to the solution and reaction mixture
stirred for 4 h and checked by TLC, solution cooled down to room temperature and the resulting
precipitate filtered and washed with EtOH and MeOH to give 8 (155 mg, 0.40 mmol, 40%) as a
yellow solid. 1H NMR (400 MHz, DMSO-d6) δ 11.61 (s, 1H), 8.00 (t, J = 1.8 Hz, 1H), 7.82 (s,
1H), 7.16 (d, J = 3.0 Hz, 1H), 6.93 (dd, J = 8.7, 3.0 Hz, 1H), 6.77 (d, J = 8.8 Hz, 1H), 6.38 (d, J =
1.7 Hz, 1H), 5.62 (t, J = 1.7 Hz, 1H), 4.48 (s, 2H), 3.69 (s, 3H), 1.40 (s, 9H). 13C}1H} NMR (101
MHz, DMSO-d6) δ 167.5, 163.9, 163.3, 152.2, 150.9, 144.5, 142.5, 121.8, 116.9, 116.0, 112.7,
110.4, 82.2, 60.6, 55.7, 50.0, 28.1. HRMS (ESI/Q-TOF) m/z: [M]+ Calcd for C19H22N4O6
402.1539; Found 402.1537
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tert-butyl 2-(2,4-dioxo-5-(4-oxo-3,4-dihydroquinazolin-2-yl)-3,4dihydropyrimidin-1(2H)-yl)acetate (36)

0.15 g, (0.4 mmol) were fully dissolved in 1 mL DMSO at 60 °C. To the same solution were added
CuCl (1.2 mg, 0.01 mmol), 4-HO-TEMPO (1 mg, 0.005 mmol), and DABCO (1 mg, 0.009 mmol),
and the mixture was stirred at 90 °C for several hours under O2 atmosphere (balloon). After
completion of the reaction (monitored by TLC), the reaction was cooled down to room temperature
and the resulting precipitate was washed with water and ethanol to give the product 1b (0.15, 0.4
mmol, 100%) as a white solid. 1H NMR (400 MHz, DMSO-d6) δ 12.46 (s, 1H), 9.27 (s, 1H), 8.38
(d, J = 7.9 Hz, 1H), 8.08 (t, J = 7.7 Hz, 1H), 7.90 (d, J = 8.2 Hz, 1H), 7.74 (t, J = 7.5 Hz, 1H), 4.96
(s, 2H), 1.71 (s, 9H).

C}1H} NMR (151 MHz, DMSO-d6) δ 166.88, 164.31, 150.51, 150.00,

13

149.16, 134.86, 126.40, 126.29, 121.54, 110.00, 103.54, 82.83, 50.85, 40.88, 40.74, 40.60, 40.47,
40.33, 40.19, 40.05, 28.22. HRMS (ESI/Q-TOF) m/z: [M]+ Calcd for C18H18N4O5 370.1277;
Found 370.1279

tert-butyl

2-(5-(6-nitro-4-oxo-1,4-dihydroquinazolin-2-yl)-2,4-dioxo-3,4-

dihydropyrimidin-1(2H)-yl) acetate (37)
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To 6-nitro substituted dihydrobenzoquinazolinone compound (0.13 g, 0.31 mmol) added 1 mL
DMSO and dissolved at 60 °C. To the same solution were added CuCl (2.9 mg, 0.02 mmol), 4HO-TEMPO (2 mg, 0.012 mmol), and DABCO (2 mg, 0.022 mmol), and the mixture was stirred
at 90 °C overnight under O2 atmosphere (balloon). After completion of the reaction (monitored by
TLC), the reaction was cooled down to room temperature and the resulting precipitate was washed
with water and ethanol to give the product as a yellow solid (0.13 g, 0.31 mmol 100%). 1H NMR
(400 MHz, DMSO-d6) δ 12.51 (s, 1H), 9.15 (s, 1H), 8.80 (d, J = 2.7 Hz, 1H), 8.55 (dd, J = 9.0, 2.8
Hz, 1H), 7.77 (d, J = 9.0 Hz, 1H), 4.74 (s, 2H), 1.46 (s, 9H). 13C}1H} NMR (101 MHz, DMSOd6) δ 167.1, 159.9, 152.2, 144.6, 129.2, 128.7, 122.6, 121.2, 82.8, 50.9, 28.1. HRMS (ESI/Q-TOF)
m/z: [M]+ Calcd for C18H17N5O7 415.1128; Found 415.1130

tert-butyl 2-(5-(7-nitro-4-oxo-1,4-dihydroquinazolin-2-yl)-2,4-dioxo-3,4dihydropyrimidin-1(2H)-yl)acetate (38)

To 7-nitro substituted dihydrobenzoquinazolinone compound (0.12 g, 0.29 mmol) added 1 mL
DMSO and dissolved at 60 °C. To the same solution were added CuCl (2.9 mg, 0.02 mmol), 4HO-TEMPO (2 mg, 0.012 mmol), and DABCO (2 mg, 0.022 mmol), and the mixture was stirred
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at 90 °C overnight under O2 atmosphere (balloon). After completion of the reaction (monitored by
TLC), the reaction was cooled down to room temperature and the resulting precipitate was washed
with water and ethanol to give the product as a yellow solid. (0.12 g, 0.29 mmol, 100%).1H NMR
(400 MHz, DMSO-d6) δ 12.50 – 12.39 (m, 2H), 9.12 (s, 1H), 8.36 – 8.27 (m, 2H), 8.18 (dd, J =
8.7, 2.2 Hz, 1H), 4.72 (s, 2H), 1.46 (s, 9H). 13C}1H} NMR (101 MHz, DMSO-d6) δ 167.1, 159.7,
151.8, 151.6, 151.4, 150.0, 149.6, 128.8, 125.7, 121.9, 119.8, 102.7, 82.8, 50.9, 28.1. HRMS
(ESI/Q-TOF) m/z: [M]+ Calcd for C18H17N5O7 415.1128; Found 415.1133

tert-butyl

2-(5-(7-methoxy-4-oxo-1,4-dihydroquinazolin-2-yl)-2,4-dioxo-3,4-

dihydropyrimidin-1(2H)-yl) acetate (39)

To 7-methoxy substituted dihydrobenzoquinazolinone compound (0.14 g, 0.35 mmol) added 1 mL
DMSO and dissolved at 60 °C. To the same solution were added CuCl (2.9 mg, 0.02 mmol), 4HO-TEMPO (2 mg, 0.012 mmol), and DABCO (2 mg, 0.022 mmol), and the mixture was stirred
at 90 °C overnight under O2 atmosphere (balloon). After completion of the reaction (monitored by
TLC), the reaction was cooled down to room temperature and the resulting precipitate was washed
with water and ethanol to give the product as a yellow solid. (0.14 g, 0.35 mmol, 100%). 1H NMR
(400 MHz, DMSO-d6) δ 12.37 (s, 1H), 12.03 (s, 1H), 9.02 (s, 1H), 8.02 (d, J = 8.7 Hz, 1H), 7.12
– 7.01 (m, 2H), 4.70 (s, 2H), 3.89 (s, 3H), 1.45 (s, 9H). 13C }1H} NMR (101 MHz, DMSO-d6) δ
167.2, 164.7, 164.5, 160.1, 151.3, 150.7, 150.1, 149.7, 128.1, 116.1, 114.8, 108.2, 103.2, 82.7,
56.1, 50.7, 28.1. HRMS (ESI/Q-TOF) m/z: [M]+ Calcd for C19H20N4O6 400.1383; Found 400.1379
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tert-butyl

2-(5-(6-methoxy-4-oxo-3,4-dihydroquinazolin-2-yl)-2,4-dioxo-3,4-

dihydropyrimidin-1(2H)-yl)acetate (40)

To 6-methoxy substituted dihydrobenzoquinazolinone compound (0.14 g, 0.35 mmol) added 1 mL
DMSO and dissolved at 60 °C. To the same solution were added CuCl (2.9 mg, 0.02 mmol), 4HO-TEMPO (2 mg, 0.012 mmol), and DABCO (2 mg, 0.022 mmol), and the mixture was stirred
at 90 °C overnight under O2 atmosphere (balloon). After completion of the reaction (monitored by
TLC), the reaction was cooled down to room temperature and the resulting precipitate was washed
with water and ethanol to give the product as a yellow solid. (0.14 g, 0.35 mmol, 100%). 1H NMR
(400 MHz, DMSO-d6) δ 12.37 (s, 1H), 12.03 (s, 1H), 9.02 (s, 1H), 8.02 (d, J = 8.7 Hz, 1H), 7.12
– 7.01 (m, 2H), 4.70 (s, 2H), 3.89 (s, 3H), 1.45 (s, 9H). 13C}1H} NMR (101 MHz, DMSO-d6) δ
167.2, 164.7, 164.5, 160.1, 151.3, 150.7, 150.1, 149.7, 128.1, 116.1, 114.8, 108.2, 103.2, 82.7,
56.1, 50.7, 28.1. HRMS (ESI/Q-TOF) m/z: [M]+ Calcd for C19H20N4O6 400.1383; Found 400.1382

tert-butyl (2-aminoethyl)glycinate (41)

6.9 mL of tBu-bromoacetate 1 mixed with 37.5 mL of Dichloromethane and added dropwise to
the mixture of 25 mL ethylenediamine (dissolved in 175 mL Dichloromethane) on the ice bath.
The reaction continued for 19 hours. Then extracted with water (90 mL ×2) and dichloromethane
(60 mL×3); dried with Sodium sulfate and concentrated in vacuo to give (15.8 g, 90 mmol, 51%)
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of ester 2 as a colorless liquid. 1H NMR (400 MHz, Chloroform-d) δ 3.22 (s, 2H), 2.74 – 2.66 (m,
2H), 2.64 – 2.52 (m, 2H), 1.39 (s, 9H).

tert-butyl (2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)ethyl)glycinate (42)

15.0 g (88 mmol) of ester 2 and 15.2 mL diisopropylethylamine (90 mmol) were added and
dissolved in 680 mL dichloromethane. 26.3 g (77mmol) of Fmoc-OSu 3 dissolved in 192 mL
Dichloromethane and added drop wisely at room temperature for 70 min. The reaction mixture
stirred overnight and washed with 1 M HCl (3×100 mL) and brine (100 mL). Organic layer dried
with sodium sulfate and filtered. The solution was partially concentrated to 50 mL in vacuo and
cooled in a deep freezer (-20 °C) overnight. The white precipitate was filtered the other day and
washed with Dichloromethane and mother liquor returned to freezer to get more product 4 (8 g,
19 mmol, 20%) as a white precipitate.

1

H NMR (400 MHz, DMSO-d6) δ 7.91 – 7.80 (m, 3H),

7.68 (dd, J = 16.3, 7.9 Hz, 2H), 7.46 – 7.23 (m, 5H), 4.36 – 4.27 (m, 2H), 4.22 (q, J = 7.3 Hz, 1H),
3.20 (s, 1H), 3.07 (q, J = 6.2 Hz, 2H), 2.58 (t, J = 6.4 Hz, 1H), 1.41 (s, 9H). 13C}1H} NMR (101
MHz, DMSO-d6) δ 171.9, 156.7, 144.4, 141.2, 129.4, 128.0, 127.7, 127.5, 125.6, 121.8, 120.6,
120.5, 110.1, 80.5, 65.8, 51.3, 48.7, 47.2, 40.8, 28.2. This corresponded closely to the NMR spectra
previously reported in the literature50.
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2-(5-(6-nitro-4-oxo-3,4-dihydroquinazolin-2-yl)-2,4-dioxo-3,4dihydropyrimidin-1(2H)-yl)acetic acid(44)

To (0.1 g, 0.24 mmol) of ester 8 added TFA (1 mL) and triethyl silane (3 drops). The reaction
stirred for 2 hours at room temperature, then the excess of the acid was evaporated under a nitrogen
stream and the product was washed by hexane and ethyl ether to give acid 9 as a yellow solid (70
mg, 0.19 mmol, 80%). 1H NMR (400 MHz, DMSO-d6) δ 13.39 (s, 1H), 12.49 (s, 11H), 9.16 (d, J
= 1.4 Hz, 9H), 8.78 (q, J = 2.6 Hz, 9H), 8.54 (dq, J = 9.1, 2.6 Hz, 10H), 7.80 – 7.72 (m, 9H), 4.76
(s, 17H), 3.17 (s, 4H). 13C}1H} NMR (101 MHz, DMSO-d6) δ 169.4, 164.5, 160.0, 152.6, 152.3,
149.9, 144.5, 129.2, 128.7, 122.6, 121.2, 102.4, 56.5, 50.3, 19.0. HRMS (ESI/Q-TOF) m/z: [M]+
Calcd for C14H9N5O7 359.0502; Found 359.0509

2-(5-(6-methoxy-4-oxo-3,4-dihydroquinazolin-2-yl)-2,4-dioxo-3,4dihydropyrimidin-1(2H)-yl)acetic acid (45)
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To (0.1 g, 0.25 mmol) of ester 8 added TFA (1 mL) and triethyl silane (3 drops). The reaction
stirred for 2 hours at room temperature, then the excess of the acid was evaporated under a nitrogen
stream and the product was washed by hexane and ethyl ether to give acid 9 as a light green solid
(65 mg, 0.19 mmol, 75%). 1H NMR (400 MHz, DMSO-d6) δ 12.32 (s, 1H), 12.13 (s, 1H), 8.95 (s,
1H), 7.59 (d, J = 8.9 Hz, 1H), 7.51 (d, J = 3.0 Hz, 1H), 7.43 (dd, J = 8.9, 3.0 Hz, 1H), 4.72 (s, 2H),
3.88 (s, 3H).

13

C}1H} NMR (101 MHz, DMSO-d6) δ 169.6, 164.5, 160.4, 157.8, 150.2, 150.1,

146.9, 143.6, 128.9, 124.8, 122.1, 106.4, 103.5, 56.1, 50.0. HRMS (ESI/Q-TOF) m/z: [M]+ Calcd
for C15H12N4O6 344.0757; Found 344.0759

tert-butyl N-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)ethyl)-N-(2-(5-(6methoxy-4-oxo-3,4-dihydroquinazolin-2-yl)-2,4-dioxo-3,4-dihydropyrimidin1(2H)-yl)acetyl)glycinate (46)
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0.1 g (0.29 mmol) of 6 dissolved in 2 mL DMF at 0 °C HOBt (26 mg, 0.20 mmol) and DCC (70
mg, 0.34 mmol) added and stirred until precipitate formed. 6 (free base) (70 mg, 0.15 mmol) added
and DMAP (1.8 mg, 0.015 mmol) added and reaction continued for 3 hours and checked by TLC.
The mixture diluted with saturated aqueous NaHCO3 and extracted with DCM and washed with
brine and concentrated in vacuo and purified by column chromatography (1:1 to 4:1 ethyl acetate
: hexanes) to yield as a white solid. (77 mg, 0.1 mmol, 66%). 1H NMR (400 MHz, DMF-d7) δ 8.31
(dd, J = 7.7, 3.6 Hz, 3H), 8.07 (dd, J = 10.0, 7.5 Hz, 3H), 7.84 (dd, J = 8.6, 6.2 Hz, 3H), 7.79 –
7.71 (m, 3H), 4.83 – 4.59 (m, 4H), 4.43 (d, J = 4.0 Hz, 2H), 4.01 (d, J = 2.4 Hz, 1H), 3.75 (s, 3H),
3.36 – 3.26 (m, 3H), 2.76 (q, J = 7.3 Hz, 1H), 1.84 (s, 9H). 13C{1H} NMR (101 MHz, DMF-d7) δ
169.99, 153.96, 144.68, 141.65, 129.81, 128.57, 128.17, 128.01, 128.00, 125.97, 122.27, 121.03,
110.63, 81.40, 68.20, 67.64, 67.23, 55.58, 55.30, 52.05, 48.40, 47.59. HRMS (ESI/Q-TOF) m/z:
[M+Na]+ Calcd for C38H38N6O9Na 745.2598; Found 745.2590.

tert-butyl N-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)ethyl)-N-(2-(5-(6nitro-4-oxo-3,4-dihydroquinazolin-2-yl)-2,4-dioxo-3,4-dihydropyrimidin1(2H)-yl)acetyl)glycinate (47)

0.1 g (0.24 mmol) of 6 dissolved in 2 mL DMF at 0 °C HOBt (23 mg, 0.19 mmol) and DCC (70
mg, 0.34 mmol) added and stirred until precipitate formed. 6 (free base) (70 mg, 0.15 mmol) added
and DMAP (1.8 mg, 0.015 mmol) added and reaction continued for 3 hours and checked by TLC.
The mixture diluted with saturated aqueous NaHCO3 and extracted with DCM and washed with
brine and concentrated in vacuo and purified by column chromatography (1:1 to 4:1 ethyl acetate
: hexanes) to yield as a yellow solid. (66 mg, 0.09 mmol, 60%). 1H NMR (400 MHz, DMSO-d6) δ
8.85 – 8.70 (m, 1H), 7.91 – 7.82 (m, 3H), 7.69 (dd, J = 10.0, 7.0 Hz, 2H), 7.47 – 7.18 (m, 5H),
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4.01 (ddd, J = 15.7, 14.1, 5.9 Hz, 1H), 3.19 (d, J = 3.2 Hz, 4H), 2.90 (s, 1H), 2.75 – 2.56 (m, 7H),
1.42 (s, 9H). 13C{1H} NMR (101 MHz, Chloroform-d) δ 171.9, 146.0, 141.0, 128.7, 127.4, 127.2,
127.1, 126.9, 126.9, 125.2, 124.7, 121.0, 119.9, 119.8, 119.7, 107.7, 81.3, 57.3, 53.0, 51.4, 48.8,
47.9, 44.7, 33.9, 31.2, 28.1. HRMS (ESI/Q-TOF) m/z: [M+Na]+ Calcd for C37H35N7O10Na
760.2343; Found 760.2350.

N-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)ethyl)-N-(2-(5-(6-methoxy4-oxo-3,4-dihydroquinazolin-2-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)yl)acetyl)glycine (48)

To (66 mg, 0.09 mmol) of ester 8 added TFA (1 mL) and triethyl silane (3 drops). The reaction
stirred for 2 hours at room temperature, then the excess of the acid was evaporated under a nitrogen
stream and the product was washed by hexane and ethyl ether to give acid 9 as a white solid (47
mg, 0.07 mmol, 75%). 1H NMR (400 MHz, DMSO-d6) δ 12.30 (s, 3H), 8.78 (s, 2H), 8.72 (s, 1H),
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7.86 (dd, J = 7.5, 5.1 Hz, 6H), 7.68 (t, J = 6.8 Hz, 6H), 7.49 (ddd, J = 8.4, 5.2, 1.6 Hz, 8H), 7.38
(dt, J = 7.9, 2.1 Hz, 6H), 7.35 – 7.29 (m, 6H), 5.57 (s, 1H), 5.03 (s, 3H), 4.84 (s, 2H), 4.36 (d, J =
6.9 Hz, 4H), 4.29 (d, J = 7.0 Hz, 2H), 4.25 (t, J = 3.4 Hz, 4H), 4.02 (s, 3H), 3.88 (s, 3H), 1.27 –
1.03 (m, 9H).13C{1H} NMR (101 MHz, DMSO) δ 172.8, 170.8, 167.2, 164.6, 160.6, 157.7, 156.8,
156.6, 150.4, 150.1, 144.3, 141.2, 141.1, 134.3, 128.1, 128.0, 127.8, 127.5, 125.6, 125.6, 120.6,
106.4, 103.1, 56.1, 49.4, 47.9, 47.2, 40.6, 40.4, 40.2, 39.9, 39.78, 39.6, 39.4, 36.7, 33.8, 25.8, 24.9.
HRMS (ESI/Q-TOF) m/z: [M+Na]+ Calcd for C34H36N6O9Na 695.2441; Found 695.2458.

N-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)ethyl)-N-(2-(5-(6-nitro-4oxo-3,4-dihydroquinazolin-2-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)yl)acetyl)glycine (49)

To (58 mg, 0.07 mmol) of ester 8 added TFA (1 mL) and triethyl silane (3 drops). The reaction
stirred for 2 hours at room temperature, then the excess of the acid was evaporated under a nitrogen
stream and the product was washed by hexane and ethyl ether to give acid 9 as a light yellow solid
(47 mg, 0.05 mmol, 83%). 1H NMR (400 MHz, DMSO-d6) δ 12.57 (s, 1H), 9.05 (d, J = 3.4 Hz,
2H), 8.81 (s, 3H), 8.55 (d, J = 8.9 Hz, 4H), 8.49 (s, 2H), 7.91 (d, J = 7.2 Hz, 3H), 7.86 (t, J = 9.8
Hz, 5H), 7.76 (dd, J = 14.8, 8.1 Hz, 6H), 7.69 (s, 3H), 7.46 – 7.29 (m, 11H), 5.07 (s, 2H), 4.87 (s,
2H), 4.68 (s, 3H), 4.13 (s, 2H), 4.03 (s, 2H), 3.56 (s, 4H), 3.28 (s, 8H), 2.92 (d, J = 21.0 Hz, 11H).
C{1H} NMR (101 MHz, DMSO-d6) δ 171.7, 169.7, 167.1, 163.5, 160.6, 157.8, 156.8, 156.6,
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150.4, 150.1, 144.3, 141.2, 141.1, 134.3, 128.1, 128.0, 127.8, 127.5, 125.6, 125.6, 120.5, 106.4,
103.1, 49.4, 47.9, 47.2, 40.6, 40.4, 40.2, 39.9, 39.8, 39.6, 39.4, 36.7, 33.8, 25.8, 24.9. HRMS
(ESI/Q-TOF) m/z: [M+Na]+ Calcd for C33H27N7O10Na 704.1717; Found 704.1739.
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Quantum Yield determination

Fluorescence quantum yields (ΦF) of the quinazolinone based monomer was determined using a
Photon Technologies International Quanta Master 7/2005 spectrophotometer by the relative
method51 using 9-10 diphenylanthracene (ΦF in EtOH = 0.95)52 and tryptophan ( ΦF in water, pH 7.2 =
0.14)53 as the reference standard in room temperature (Table S2). The quantum yields were
determined using the integrated fluorescence intensity and an average of five emission scans for
each compound and as a triplicate for each calculation. The quantum yield of the unknown Φ(x)
can be calculated by the following equation:
Is
Abs ref
η2 s
).(
) . ( 2 ) . Φ ref
Φs = (
Iref
Abs s
η ref
Where Φ(ref) is the quantum yield of the standard, Abs is the absorbance at the excitation
wavelength, I is the integrated area in the emission curve, the subscripts s and ref refer to unknown
and standard respectively and η is the refractive index of the solvent. By measuring a series of
diluted solutions with various absorbance readings the following equation may be used:
Grad s
η2 s
) . ( 2 ) . Φ ref
Φs = (
Grad ref
η ref
Where Grad is the gradient from the plot of the integrated area in the emission curve versus
absorbance at the excitation wavelength.
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Chapter 4
Conclusion and Outlook
PART 1:

The synthesis of a Fmoc protected thiouracil PNA monomers has been completed after the
investigation of different highly acid-labile protecting groups for 2-thione group. This study has
shown that the 4-methoxybenzyl protecting group that has been used for Boc-based
oligomerization of pcPNA synthesis containing thiouracil residues is also suitable for Fmoc-based
oligomerization. Moreover, the 2-methoxybenzyl protecting group was surprisingly robust and the
origin of the resistance to acidolysis for the 2-methoxy group appears to be intramolecular
stabilization of the protonated species; this extra stability cannot be expected without this particular
structural feature. Also, considering the deprotection condition in Boc-based solid-phase peptide
synthesis as the thiouracil protection most likely does not persist for Boc-based oligomer synthesis
we hypothesized that having the acid-labile sulfur protection is not necessary during the
oligomerization. Thus, the oligomerization of a 10-mer PNA sequence was completed with
minimum evidence of an increase in truncation products and comparable purity to the previously
synthesized PNA sequences using 2-thiouracil protected monomers. Thus, it was found that the
protecting group is only necessary during the preparing thiouracil PNA monomer and it can be
cleaved prior to the oligomerization. The Fmoc/Boc protected PNA monomer has also been
synthesized for 2,6-diaminopurine and used in the synthesis of pseudo-complementary PNA
sequences in order to destabilize the PNA-PNA duplex more.
In order to study the DNA strand invasion we developed a new technique which uses the
fluorescent analysis. The study of DNA strand invasion using fluorescent techniques, the analyses
of the results from melting curves demonstrate that the replacement of a C base with PhpC resulted
in an increase in melting temperature. Secondly, as expected, a general increase in melting
temperature was observed between DNA-PNA hetero-duplexes. Even though the PNA sequences
were two base pairs shorter than their DNA partner, the decrease in repulsion due to the neutrality
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of the PNA backbone resulted in increased Tm values. Finally, it appears that with regards to DNAPNA bonding, ST in PNA has a slightly stronger bonding interaction with DNA than does a SU
base. This was consistent across all cases when bonding to either the target DNA or target DNA
(PhpC). Interestingly, when bonding to complementary PNA this phenomenon is reversed. This
phenomenon requires further investigation but likely is a result of the different conformation of
PNA-DNA versus PNA-PNA duplexes. The sU and D monomer incorporation into a PNA shows
that and its melting temperature against PNA and DNA shows that the synthesis of PNA sequences
containing more pseudo-complementary bases can destabilize the PNA-PNA duplex while the
DNA-PNA duplex is more stable. Fluorescence measurements were highly successful and were
supportive of the original hypothesis. The target DNA (PhpC) baseline was initially compared to
the target DNA (PhpC) pared to cDNA. The change between the “ON” and “OFF” states
respectively was clearly evident as an overall change in fluorescence was approximately two-fold.
Also, as expected, the fluorescence of the DNA-PNA hybrids in the “ON” state was intermediate
between the free target DNA (PhpC) strand and its “OFF” partner. These results are encouraging
because it is evident that a simple change in a binding partner can be used to induce a measurable
change in fluorescence corresponding to its identity.

PART 2:

Synthesis of PNA monomer carrying functionalized quinazolinone moiety and study of the
effect of electron-withdrawing and electron-donating groups has been done. The characterization
by fluorescence quantum yield response in different solvents and three different temperatures
shows a promising result. Based on the fluorescence studies, methoxy group as an electrondonating group on the 6-position has the highest fluorescence quantum yield. Quinazolinone-based
uracil scaffolds show greater fluorescence quantum yields than dihydroquinazolinone compounds.
Moreover, the observed emission spectra in lower temperature or glycerol as a more viscous
solvent, show higher fluorescence quantum yields. It can be explained by the molecular 3D
structure and rigidity as well as the hydrogen bonding between O4 in uracil ring with amide in the
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heterocycle ring. So, these uracil analogues can be used as a reporter in PNA probes with expected
stabilization of the formed duplex structure.
These results indicate that the PNA probe containing quinazolinone moiety may be a good
candidate for reporting binding events by showing “ON-OFF” target effects upon hybridization to
complementary nucleobases. In order to study these fluorescence uracil analouges in oligomer
level, the incorporation of quinazolinone-based PNA monomer into PNA oligomer was done. Two
different PNAs have been synthesized and their thermal melting point and fluorescent response
upon hybridization with complementary DNA sequences will be studied as the future work. This
PNA oligomer may be used as a reporter probe. Based on the fluorescence quantum yield of
quinazolinone-based uracil compounds in different solvents and temperatures, the quinazolinone
containing PNA probe may be used to monitor the state of hybridization by stabilizing the duplex
structure and fluorescence response (single-stranded or duplex structure).
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General synthetic procedures
All chemicals were obtained from commercial sources and were of ACS
reagent grade or higher and were used without further purification. Anhydrous and HPLC-grade
solvents for PNA synthesis and chromatography were purchased from Caledon Laboratories. All
other solvents were dried by passing through activated alumina columns. In all cases, sodium
sulfate was used as the drying agent and solvent was removed by reduced pressure with Buchi
Rotavapor. Thin-layer chromatography was performed on Silicycle Silica Gel TLC F-254 plates.
Unless otherwise specified the Rf values are reported in the solvent system the reaction was
monitored in. Flash chromatography was performed with Silicycle SiliaFlash® F60 230-400 mesh
silica. All chemical shifts are reported in parts per million (δ), from tetramethylsilane (0 ppm), and
are referenced to the residual proton in the respective solvent: CDCl3 (7.26 ppm), DMSO-d6 (2.49
ppm), methanol-d6 (3.31 ppm) for 1H NMR and CDCl3 (77.0 ppm) and DMSO-d6 (39.5 ppm) and
methanol-d6 (49.0 ppm) for

13

C NMR. Multiplicities are described as s (singlet), d (doublet), t

(triplet), q (quartet), m (multiplet) and br s (broad singlet). Coupling constants (J) are reported in
Hertz (Hz). Spectra were obtained on Bruker-400 and INOVA-400 and INOVA-600 instruments.
The 1H NMR and

13

C NMR for PNA monomers performed in CDCl3 show the presence of

rotamers. High-resolution mass spectra (HRMS) were obtained using electrospray ionization
(ESI).

Acidolysis studies and half-life calculations
The change in the benzylic integration over time was plotted to fit a first-order reaction
curve with the natural logarithm of the benzylic proton integration against the reaction time
(Figure S1). A first-order reaction is dependent on the concentration of a single reactant (Eq. 1),
thus the rate equation is expressed as:
𝑟𝑎𝑡𝑒 = −

𝑑[𝐴]
= 𝑘[𝐴]
𝑑𝑡

The integration of the first-order rate equation (Eq. 2) yields a linear equation (Eq. 3) with respect
to the natural logarithm of the concentration of the reactant. By considering when the reaction

S2

concentration has diminished by one-half (Eq. 4), an expression for the half-life of reaction
emerges, (Eq. 5)
[𝐴] 𝑑[𝐴]
[𝐴]

∫[𝐴]𝑜

𝑡

= ∫𝑡 −𝑘𝑑𝑡
𝑜

ln[𝐴] − ln[𝐴]𝑜 = −𝑘𝑡
1

=𝑒
2

−𝑘𝑡1

𝑡1 = −
2

2

ln 2
𝑘

(2)

(3)

(4)

(5)

Using the rate constant determined from Figure S1, the half-life of the acidolysis was estimated.

S3

Time course studies on the acidolysis of thioesters

Figure S1. 1H NMR spectra of ethyl 2-(2-((4-methoxybenzyl)thio)uracil-1 yl)acetate (12a)
acidolysis in a solution of 2% TFA and 1% triethylsilane in CDCl3. Benzylic methylene (*), N1methylene (x).
S4

Figure S2. 1H NMR spectra of ethyl 2-(2-(2-methoxybenzyl)thio)uracil-1-yl)acetate (14a)
acidolysis in a solution of 2% TFA and 1% triethylsilane in CDCl3. Benzylic methylene (*), N1methylene (x).
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Figure S3. First order reaction curves for a) ethyl 2-(2-(S-(4 methoxybenzyl)thiouracil-1yl)acetate, 12a, 17), and b) ethyl 2-(2-S-(2 methyl-4-methoxybenzyl)thiouracil-1-yl)acetate,
9 treated with 2% TFA, 1% TES in CDCl3.
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Oligomer synthesis
PNA oligomers were synthesized using the ABI 433A peptide synthesizer manufactured
by Perkin Elmer Applied Biosystems. Oligomerization was carried out using newly synthesized
s

U monomer, commercially available PNA monomers: Fmoc-A(Bhoc)-AEG-OH, Fmoc-G(Bhoc)-

AEG-OH, and Fmoc-C(Bhoc)-AEG-OH, Fmoc-T(Bhoc)-AEG-OH (purchased from PolyOrg,
Inc.), and Nα-Fmoc-Nε-Boc-L-lysine (purchased from Chem-Impex Int’l Inc.), using standard
Fmoc-based solid-phase synthesis protocol. Fmoc-RAM-PS was used as a solid support resin
preloaded with lysine at 0.057 mmol/g. The synthesis was carried out on a 5.0 µmol scale.
Monomers were prepared with 25 µmol dissolved in 110 µL. Solutions of 0.4 M
diisopropylethylamine in N-methyl-2-pyrrolidone (NMP) and 0.19 M HBTU in NMP were
prepared for monomer coupling. Fmoc deprotection was performed using a solution of 20% 4methylpiperidine in dimethylformamide. Unreacted terminal amino groups were capped with
acetic anhydride, using a solution of 1:25:25 acetic anhydride: pyridine: NMP. Following
automated synthesis, the resin was treated with a solution of 95 % trifluoroacetic acid and 5%
triethylsilane to cleave the oligomer from the resin and remove the protecting group from the
nucleobases (Bhoc) and amino group (Boc). The solvent was then evaporated under a nitrogen
stream, the resulting residue was washed twice with cold ether, dissolved in a solution of 0.05%
trifluoroacetic acid in water then purified by reverse-phase HPLC. Reverse-phase HPLC was
performed on an Agilent Microsorb-MV 100-5 C18 250 × 4.6 mm column heated to 50 °C. The
purified PNA oligomer was eluted using a gradient (water/0.1 % trifluoroacetic acid to
acetonitrile/0.1 % trifluoroacetic acid).

RP-HPLC conditions and chromatograms
For PNA oligomers: 0-50% B in 50 min and 50-100% B in 10 min (Mobile phase A: H2O
containing 0.1% TFA. Mobile phase B: acetonitrile containing 0.1% TFA) (unless otherwise
stated). For DNA oligomers: 0-20% A in 20 min and 20-100% A in 10 min (Mobile phase A:
Acetonitrile. Mobile phase B: 0.1 M TEAA buffer). The flow rate was 1 mL/min.
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RP-HPLC chromatograms of the crude (a) and pure (b) PNA oligomer H-Lys-AGTGATCTACLys-NH2

(a)

(b)
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RP-HPLC chromatograms of the crude (a) and pure (b) PNA oligomer H-Lys-GsUAGAsUCACsU-Lys-NH2
(no PG for thiouracil)

(a)

(b)
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RP-HPLC chromatograms of the crude (a) and pure (b) PNA oligomer H-LysGsUAGAsUCACsU-Lys-NH2

(a)

(b)
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RP-HPLC chromatograms of the crude (a) and pure (b) PNA oligomer H-LysGsTAGAsTCACsT-Lys-NH2

(a)

(b)
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RP-HPLC chromatograms of the crude (a) and pure (b) PNA oligomer H-Lys-AGsUGAsUCsUACLys-NH2 *

(a)

(b)

*0-50%

B in 50 min and 50-100% B in 10 min (Mobile phase A: H2O containing 0.1% TFA.

Mobile phase B: acetonitrile containing 0.1% TFA)
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RP-HPLC chromatograms of the crude (a) and pure (b) PNA oligomer H-LysDGsUGDsUCsUDC-Lys-NH2*

(a)

(b)

*0-50%

B in 50 min and 50-100% B in 10 min (Mobile phase A: H2O containing 0.1% TFA.

Mobile phase B: acetonitrile containing 0.1% TFA)
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RP-HPLC chromatograms of the crude (a) and pure (b) PNA oligomer H-Lys-GsUDGDsUCDCTLys-NH2*

(a)

(b)

*0-50%

B in 50 min and 50-100% B in 10 min (Mobile phase A: H2O containing 0.1% TFA.

Mobile phase B: acetonitrile containing 0.1% TFA)
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RP-HPLC chromatograms of the (a) crude (DMT-on) and (b) pure (DMT-off) PNA oligomer 5’
AGTGATCTACCT 3’

(a)

(b)
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RP-HPLC chromatograms of the (a) crude (DMT-on) and (b) pure (DMT-off) PNA oligomer 5’
AGGTAGATCACT 3’ were used.

(a)

(b)
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RP-HPLC chromatograms of the (a) crude (DMT-on) at 260 nm and (b) crude (DMT-on) at 360
nm (c) pure (DMT-on) at 260 nm (d) pure (DMT-on) at 360 nm (e) pure (DMT-off) at 260 nm
PNA oligomer 5’ AGTGATCTAC(PhpC)T 3’

(a)

(b)
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(c)

(d)
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(e)
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Sequencea

Molecular formula

Calculated
[M+Na]+

Observed
[M+Na]+

H-Lys-AGTGATCTAC-Lys-NH2

C120H159N61O33Na

3005.2536

3005.2929

H-Lys-GTAGATCACT-Lys-NH2

C120H159N61O33Na

3005.2536

3005.2551

H-Lys-GsUAGAsUCACsU-Lys-NH2

C117H153N61O30S3Na

3011.1382

3011.2430

H-Lys-GsUAGAsUCACsU-Lys-NH2 c

C117H153N61O30S3Na

3011.1382

3011.2624

H-Lys-GsTAGAsTCACsT-Lys-NH2

C120H159N61O30S3Na2

1538.0874b 1538.0963b

H-Lys-AGsUGAsUCsUAC-Lys-NH2

C117H153N61O30S3Na

3011.1382

H-Lys-DGsUGDsUCsUDC-Lys-NH2

C117H156N64O30S3Na2

1539.5803b 1539.6721b

H-Lys-GsUDGDsUCDCT-Lys-NH2

C118H158N64O31S2Na2

1538.5996b 1538.7134b

(N

C)

a

PNA sequences possess a free N-terminal amino group and C-terminal amide

b

Oligomer calculated and observed as the dicationic [M+2Na]2+

c

PNA sequences didn’t have thiouracil protection during oligomerization

3011.1431

Table S1. Observed high-resolution mass of synthesized PNA oligomers

Reference Fluorophore

Φ (EtOH)

Φ (DMSO)

Φ (THF)

Φ (Glycerol)

0.95a

0.27

0.42

0.89

23

0.79

0.24

0.81

60

9,10-diphenylanthracene

Φ (water, pH 7.2)

0.95

15
0.27

0.35

0.31

0.14a

0.28
Tryptophan
a

T (°C)

23
60
15

Values extracted from literature.52,53

Table S2. Calculated quantum yield values for reference standards in different solvents
and temperatures
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Figure S4. Emission at 446 nm of single-stranded Target DNA (PhpC) upon excitation from
300 nm to 440 nm.
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UV-vis absorbance and Beer-Lambert Plots
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Emission spectra for compound 40 in different solvents and temperatures
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4 uM

2 uM
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Fluorescent intensity (CPS)

40 in EtOH at 60 °C
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4 uM

2 uM

630

NMR Spectra
1

H NMR spectrum of 4-methoxybenzyl alcohol (2)
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1

H NMR spectrum of 2-((4-methoxybenzyl)thio)pyrimidin-4(1H)-one (5)

S31

13

C NMR spectrum of 2-((4-methoxybenzyl)thio)pyrimidin-4(1H)-one (5)
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1

H NMR spectrum of N-1-(Ethyloxycarboxymethyl)-S-(4-methoxybenzyl)-2thiouracil (6a)
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13

C NMR spectrum of N-1-(Ethyloxycarboxymethyl)-S-(4-methoxybenzyl)-2thiouracil (6a)
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1

H NMR spectrum of 2-(2-methoxybenzyl) thiouracil (10)

S35

13

C NMR spectrum of 2-(2-methoxybenzyl) thiouracil (10)
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1

H NMR spectrum of N-1-(Ethyloxycarboxymethyl)-S-(2-methoxybenzyl)-2thiouracil (11a)
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13

C NMR spectrum of N-1-(Ethyloxycarboxymethyl)-S-(2-methoxybenzyl)-2thiouracil (11a)
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COSY and HSQC spectrum of N-1-(Ethyloxycarboxymethyl)-S-(2methoxybenzyl)-2-thiouracil (11a)
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HMBC spectrum of N-1-(Ethyloxycarboxymethyl)-S-(2-methoxybenzyl)-2thiouracil (11a)
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1

H NMR spectrum of 2-(2-((4-methoxybenzyl)thio)-4-oxopyrimidin-1(4H)yl)acetic acid (12)
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13

C NMR spectrum of 2-(2-((4-methoxybenzyl)thio)-4-oxopyrimidin-1(4H)yl)acetic acid (12)
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1

H NMR spectrum of methyl (2-((((9H-fluoren-9yl)methoxy)carbonyl)amino)ethyl)glycinate (14)
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13

C NMR spectrum of methyl (2-((((9H-fluoren-9yl)methoxy)carbonyl)amino)ethyl)glycinate (14)
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1

H NMR spectrum of methyl N-(2-((((9H-fluoren-9yl)methoxy)carbonyl)amino)ethyl)-N-(2-(2-((4-methoxybenzyl)thio)-4oxopyrimidin-1(4H)-yl)acetyl)glycinate (15)
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1

H NMR spectrum of N-(2-((((9H-fluoren-9yl)methoxy)carbonyl)amino)ethyl)-N-(2-(2-((4-methoxybenzyl)thio)-4oxopyrimidin-1(4H)-yl)acetyl)glycine (16)
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13

C
NMR
spectrum
of
N-(2-((((9H-fluoren-9yl)methoxy)carbonyl)amino)ethyl)-N-(2-(2-((4-methoxybenzyl)thio)-4oxopyrimidin-1(4H)-yl)acetyl)glycine (16)
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1

H
NMR
spectrum
of
N-(2-((((9H-fluoren-9yl)methoxy)carbonyl)amino)ethyl)-N-(2-(4-oxo-2-thioxo-3,4dihydropyrimidin-1(2H)-yl)acetyl)glycine (17)

S48

13

C
NMR
spectrum
of
N-(2-((((9H-fluoren-9yl)methoxy)carbonyl)amino)ethyl)-N-(2-(4-oxo-2-thioxo-3,4dihydropyrimidin-1(2H)-yl)acetyl)glycine (17)

S49

1

H NMR spectrum of tert-butyl 2,6-bis(bis(tert-butoxycarbonyl)amino)-9Hpurine-9-carboxylate (19)
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13

C NMR spectrum of tert-butyl 2,6-bis(bis(tert-butoxycarbonyl)amino)-9Hpurine-9-carboxylate (19)

S51

1

H NMR spectrum of di-tert-butyl (9H-purine-2,6-diyl)bis((tert-

butoxycarbonyl)carbamate) (20)
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13

C NMR spectrum of di-tert-butyl (9H-purine-2,6-diyl)bis((tert-

butoxycarbonyl)carbamate) (20)
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1

H NMR spectrum of benzyl 2-(2,6-bis(bis(tert-butoxycarbonyl)amino)-9H-

purin-9-yl)acetate (21)
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13

C NMR spectrum of benzyl 2-(2,6-bis(bis(tert-butoxycarbonyl)amino)-9H-

purin-9-yl)acetate (21)
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1

H NMR spectrum of 2-(2,6-bis(bis(tert-butoxycarbonyl)amino)-9H-purin-9-

yl)acetic acid (22)
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13

C NMR spectrum of 2-(2,6-bis(bis(tert-butoxycarbonyl)amino)-9H-purin-9-

yl)acetic acid (22)
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1

H NMR spectrum of benzyl N-(2-((((9H-fluoren-9yl)methoxy)carbonyl)amino)ethyl)-N-(2-(2,6-bis(bis(tertbutoxycarbonyl)amino)-9H-purin-9-yl)acetyl)glycinate(23)
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13

C NMR spectrum of benzyl N-(2-((((9H-fluoren-9yl)methoxy)carbonyl)amino)ethyl)-N-(2-(2,6-bis(bis(tertbutoxycarbonyl)amino)-9H-purin-9-yl)acetyl)glycinate(23)

S59

1

H NMR spectrum of N-(2-((((9H-fluoren-9-

yl)methoxy)carbonyl)amino)ethyl)-N-(2-(2,6-bis(bis(tertbutoxycarbonyl)amino)-9H-purin-9-yl)acetyl)glycine (24)
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13

C NMR spectrum of N-(2-((((9H-fluoren-9-

yl)methoxy)carbonyl)amino)ethyl)-N-(2-(2,6-bis(bis(tertbutoxycarbonyl)amino)-9H-purin-9-yl)acetyl)glycine (24)
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1

H NMR spectrum of 5-Formyluracil (25)
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13

C NMR spectrum of 5-Formyluracil (25)
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1

H NMR spectrum of tert-Butyl (uracil-5-formaldehyde-1-yl) acetate (26)
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13

C NMR spectrum of tert-Butyl (uracil-5-formaldehyde-1-yl) acetate (26)
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1

H NMR spectrum of 2-Amino-5-methoxybenzamide (27)
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13

C NMR spectrum of 2-Amino-5-methoxybenzamide (27)
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1

H NMR spectrum of 2-Amino-5-nitrobenzamide (28)
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13

C NMR spectrum of 2-Amino-5-nitrobenzamide (28)
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1

H NMR spectrum of 2-Amino-4-methoxybenzamide (29)
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1

H NMR spectrum of 2-Amino-4-nitrobenzamide (30)
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1

H NMR spectrum of tert-butyl 2-(2,4-dioxo-5-(4-oxo-1,2,3,4tetrahydroquinazolin-2-yl)-3,4-dihydropyrimidin-1(2H)-yl)acetate (31)
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13

C NMR spectrum of tert-butyl 2-(2,4-dioxo-5-(4-oxo-1,2,3,4tetrahydroquinazolin-2-yl)-3,4-dihydropyrimidin-1(2H)-yl)acetate (31)
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1

H NMR spectrum of tert-butyl 2-(5-(6-nitro-4-oxo-1,2,3,4-

tetrahydroquinazolin-2-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl) acetate
(32)
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13

C NMR spectrum of tert-butyl 2-(5-(6-nitro-4-oxo-1,2,3,4-

tetrahydroquinazolin-2-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl) acetate
(32)
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1

H NMR spectrum of tert-butyl 2-(5-(7-nitro-4-oxo-1,2,3,4-

tetrahydroquinazolin-2-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl) acetate
(33)

S76

13

C NMR spectrum of tert-butyl 2-(5-(7-nitro-4-oxo-1,2,3,4-

tetrahydroquinazolin-2-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl) acetate
(33)
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1

H NMR spectrum of tert-butyl 2-(5-(7-methoxy-4-oxo-1,2,3,4-

tetrahydroquinazolin-2-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl) acetate
(34)
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13

C NMR spectrum of tert-butyl 2-(5-(7-methoxy-4-oxo-1,2,3,4-

tetrahydroquinazolin-2-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl) acetate
(34)
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1

H NMR spectrum of tert-butyl 2-(5-(6-methoxy-4-oxo-1,2,3,4-

tetrahydroquinazolin-2-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl) acetate
(35)
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13

C NMR spectrum of tert-butyl 2-(5-(6-methoxy-4-oxo-1,2,3,4-

tetrahydroquinazolin-2-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl) acetate
(35)
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1

H NMR spectrum of tert-butyl 2-(2,4-dioxo-5-(4-oxo-3,4-dihydroquinazolin-

2-yl)-3,4-dihydropyrimidin-1(2H)-yl)acetate (36)
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13

C NMR spectrum of tert-butyl 2-(2,4-dioxo-5-(4-oxo-3,4-dihydroquinazolin-

2-yl)-3,4-dihydropyrimidin-1(2H)-yl)acetate (36)
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1

H NMR spectrum of tert-butyl 2-(5-(6-nitro-4-oxo-1,4-dihydroquinazolin-2-

yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl) acetate (37)

S84

13

C NMR spectrum of tert-butyl 2-(5-(6-nitro-4-oxo-1,4-dihydroquinazolin-2-

yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl) acetate (37)
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1

H NMR spectrum of tert-butyl 2-(5-(7-nitro-4-oxo-1,4-dihydroquinazolin-2-

yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetate (38)

S86

13

C NMR spectrum of tert-butyl 2-(5-(7-nitro-4-oxo-1,4-dihydroquinazolin-2-

yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetate (38)
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1

H NMR spectrum of tert-butyl 2-(5-(7-methoxy-4-oxo-1,4-dihydroquinazolin-

2-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl) acetate (39)

S88

13

C NMR spectrum of tert-butyl 2-(5-(7-methoxy-4-oxo-1,4-dihydroquinazolin-

2-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl) acetate (39)

S89

1

H NMR spectrum of tert-butyl 2-(5-(6-methoxy-4-oxo-3,4-dihydroquinazolin-

2-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetate (40)
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13

C NMR spectrum of tert-butyl 2-(5-(6-methoxy-4-oxo-3,4-dihydroquinazolin-

2-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetate (40)
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1

H NMR spectrum of tert-butyl (2-aminoethyl)glycinate (41)
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1

H NMR spectrum of tert-butyl (2-((((9H-fluoren-9-

yl)methoxy)carbonyl)amino)ethyl)glycinate (42)
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13

C NMR spectrum of tert-butyl (2-((((9H-fluoren-9-

yl)methoxy)carbonyl)amino)ethyl)glycinate (42)
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1

H NMR spectrum of 2-(5-(6-nitro-4-oxo-3,4-dihydroquinazolin-2-yl)-2,4-

dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetic acid(44)
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1

H NMR spectrum of 2-(5-(6-methoxy-4-oxo-3,4-dihydroquinazolin-2-yl)-2,4dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetic acid (45)
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13

C NMR spectrum of 2-(5-(6-methoxy-4-oxo-3,4-dihydroquinazolin-2-yl)-2,4dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetic acid (45)
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1

H NMR spectrum of tert-butyl N-(2-((((9H-fluoren-9-

yl)methoxy)carbonyl)amino)ethyl)-N-(2-(5-(6-methoxy-4-oxo-3,4dihydroquinazolin-2-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)yl)acetyl)glycinate (46)
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13

C NMR spectrum of tert-butyl N-(2-((((9H-fluoren-9-

yl)methoxy)carbonyl)amino)ethyl)-N-(2-(5-(6-methoxy-4-oxo-3,4dihydroquinazolin-2-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)yl)acetyl)glycinate (46)
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1

H

NMR

spectrum

of

tert-butyl

N-(2-((((9H-fluoren-9-

yl)methoxy)carbonyl)amino)ethyl)-N-(2-(5-(6-nitro-4-oxo-3,4dihydroquinazolin-2-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)yl)acetyl)glycinate (47)
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13

C NMR spectrum of tert-butyl N-(2-((((9H-fluoren-9-

yl)methoxy)carbonyl)amino)ethyl)-N-(2-(5-(6-nitro-4-oxo-3,4dihydroquinazolin-2-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)yl)acetyl)glycinate (47)

S101

1

H NMR spectrum of N-(2-((((9H-fluoren-9-

yl)methoxy)carbonyl)amino)ethyl)-N-(2-(5-(6-methoxy-4-oxo-3,4dihydroquinazolin-2-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)yl)acetyl)glycine (48)

S102

13

C NMR spectrum of N-(2-((((9H-fluoren-9-

yl)methoxy)carbonyl)amino)ethyl)-N-(2-(5-(6-methoxy-4-oxo-3,4dihydroquinazolin-2-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)yl)acetyl)glycine (48)

S103

1

H NMR spectrum of N-(2-((((9H-fluoren-9-

yl)methoxy)carbonyl)amino)ethyl)-N-(2-(5-(6-nitro-4-oxo-3,4dihydroquinazolin-2-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)yl)acetyl)glycine (49)

S104

13

C NMR spectrum of N-(2-((((9H-fluoren-9-

yl)methoxy)carbonyl)amino)ethyl)-N-(2-(5-(6-nitro-4-oxo-3,4dihydroquinazolin-2-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)yl)acetyl)glycine (49)
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2013-2017
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